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INTRODUCTION 
The loss of income from lactation ketosis in high-
producing dairy cows always has been a major concern for the 
dairy industry. Although appreciable research has been done 
in this field, the etiology of bovine lactation ketosis is not 
completely understood. There have been several reviews of 
bovine lactation ketosis (7, 10, 11, 127, 189), and the 
reviewers all seem to agree that lactation ketosis can be 
divided into two stages: subclinical and clinical, with the 
former stage occurring before the latter. 
Clinical ketosis is accompanied by signs such as 
lethargy, loss of appetite, and decreased milk production. 
The incidence of ketosis in individual herds has been 
estimated to range from 2 to 37% in dairy cows of the United 
States and Western Europe (7, 52, 204). The total loss to the 
U. S. dairy industry from this disease was estimated to be 
$150 million several years ago (146); more recent figures are 
unavailable. Ketosis prevents many of the best dairy cows 
from reaching their full potential. This metabolic disorder 
almost always occurs during the first 10 days to 8 weeks after 
calving. More cases seem to occur in winter (256). 
Lactation is a time of great energy stress to cows, 
because of the enormous demand for glucose and total energy 
that nature imposes upon them. The fact that ruminants depend 
2 
upon gluconeogenesis for most of their glucose supply renders 
them more vulnerable to ketosis. During lactation, the liver, 
which is the primary site of gluconeogenesis, is sometimes 
unable to synthesize enough glucose to meet the demands 
imposed by the mammary gland for lactose synthesis. The 
resulting hypoglycemia indirectly causes adipose tissue to 
accelerate the release of fatty acids and glycerol. The liver 
may oxidize these fatty acids to ketone bodies to provide 
energy for muscle and other peripheral tissues, and thereby 
conserve glucose. Under normal circumstances, metabolic 
adjustments allow cows to function normally and to maintain 
optimal body health and milk production. Some cows, however, 
do not respond favorably to these metabolic changes during 
lactation; their metabolic mechanisms "break down" and result 
in increased ketonemia and hypoglycemia, consequently leading 
to the metabolic disorder known as lactation ketosis. 
For many years, cows have been bred and fed by animal 
husbandmen and nutritionists until they haves become 
biological factories capable of producing enormous quantities 
of milk. In today's high-technology world, there is a demand 
for more efficient milk production; to this end, there have 
been several attempts to modify the delicate metabolic balance 
of cows. Examples of methods to boost milk production are 
treatment with exogenous hormones such as bovine 
somatotrophin, improved genetic selection, and increased use 
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of grain and supplemental fat in feeds. Technologies such as 
these do not eliminate the incidence of ketosis. Several 
methods of treating ketosis have been documented and include 
use of propylene glycol (67, 78, 184, 198), niacin (62, 70, 
77, 177), and monensin (196, 203). 
Rather than focus on new methods of treatment, it seems 
more logical to delve directly at the root of the problem and 
try to prevent ketosis. Thus, there is a current emphasis on 
describing the metabolic changes that occur during development 
of ketosis. Such a metabolic picture would enable a mechanism 
of development to be elucidated, which, in turn, should point 
toward proper methods for treatment or prevention. An 
effective protocol has been developed for inducing ketosis in 
early-lactating cows (168), that involves moderate feed 
restriction and feeding a ketone body precursor, 1,3-
butanediol, and has made it possible for researchers to 
investigate the sequential events as ketosis develops. 
The present studies were conducted to further describe 
the model system that has been used for development of bovine 
lactation ketosis. During lactation, when the demand for milk 
production increases the need for glucose, gluconeogenesis 
increases. This increase is reflected in greater activity of 
gluconeogenic enzymes such as pyruvate carboxylase, which 
converts pyruvate to oxaloacetate and for which acetyl CoA is 
an obligatory cofactor. Increased phosphoenoIpyruvate 
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carboxykinase (PEPCK) activity then would push oxaloacetate 
toward formation of glucose. If the liver already has a great 
influx of fatty acids from the adipose tissue, then it may not 
synthesize protein and phospholipid fast enough to export 
lipoproteins appropriately. Consequently, triacylglycerols 
accumulate in the liver, causing fatty liver. The presence of 
fatty liver, coupled with a shortage of oxaloacetate for use 
in the citric acid cycle and a high ratio of NADH to NAD+, 
would lead to a buildup of acetyl CoA in liver, which 
subsequently would lead to increased formation of ketone 
bodies. Recent studies (168) have suggested that 
gluconeogenesis decreases around the time that clinical 
symptoms of ketosis become evident. This decreased 
gluconeogenesis presumably should be reflected in the activity 
of the key gluconeogenic enzyme, PEPCK, suggesting some 
aberration in the expression of the gene for PEPCK. 
In the current study, changes in expression of the PEPCK 
gene have been measured with respect to the period of 
lactation when cows are most susceptible to development of 
ketosis. An attempt also was made to sequence part of the 
bovine PEPCK gene by using the polymerase chain reaction. The 
specific objectives of this study are as follows: 
(1) to study changes in amounts of PEPCK mRNA during 
lactation in dairy cows, 
(2) to study the changes in amounts of PEPCK protein 
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during the same period of time, 
(3) to correlate PEPCK mRNA and protein data to 
provide a "picture" of PEPCK gene expression during 
lactation, 
(4) to relate changes in PEPCK gene expression to 
development of bovine lactation ketosis, and 
(5) to amplify part of the bovine liver cytosolic PEPCK 
gene by using the polymerase chain reaction. 
Explanation of dissertation format 
This dissertation is presented in the alternative format, 
as outlined in the Iowa State University Graduate College 
Thesis Manual. The alternate format allows preparation of 
independent sections, each of which can be used for submission 
for publication in a scientific journal. 
Two separate papers have been prepared from research 
performed to partially fulfill requirements for the Ph.D. 
degree. Each paper is complete in itself and has an abstract, 
introduction, methods, results and discussion, general 
discussion, and references. A Review of Literature precedes 
the papers and a General Summary follows the papers. 
Literature cited in the Introduction and Review of Literature 
follow the latter, while those cited in the General Summary 
follow the Summary. 
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REVIEW OF LITERATURE 
This review of literature presents the discovery, 
regulation, and advances in molecular biology of PEPCK in 
perspective with the development and physiological 
implications of bovine lactation ketosis. The two main topics 
that will be discussed are lactation ketosis and PEPCK. 
I. Lactation ketosis 
Incidence of ketosis 
Ketosis is an "occupational hazard" of high-producing 
dairy cows. This metabolic disease prevents many of the 
better dairy cows from reaching their full production 
potential. In other words, cows fail to "peak" in milk 
production after parturition and never produce up to their 
potential. This "lost" milk production results in enormous 
economic losses to dairy farmers every year. Ketosis almost 
always occurs during the first 10 days to 8 weeks of calving 
(256). Ketosis occurs with greater frequency in winter, which 
is also when more cows tend to calve (229). The incidence of 
ketosis is greater in older cows, and certain cows tend to 
repeat; ketosis, however, also can occur at first calving. 
Lactation ketosis affects approximately 2 to 37% of dairy cows 
in individual herds in the United States and Western Europe 
(7, 52, 146, 204). 
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Ketosis can be divided into two stages—subclinical and 
clinical. Subclinical ketosis was recorded most frequently in 
the second to third week after parturition. It is generally 
accepted that clinical ketosis is an extreme manifestation of 
subclinical ketosis (7, 76). Cows usually return to positive 
energy balance before 75 days postpartum and do not develop 
ketosis after that time (210). Decreased milk production, 
rapid loss of body weight with a sudden decrease in appetite, 
and lethargy are some of the symptoms of ketosis (69, 209). 
Hypoglycemia, hypoinsulinemia, hyperketonemia, decreased 
hepatic glycogen, increased hepatic triacylglycerols, and 
increased nonesterified fatty acids (NEFA) in blood are some 
of the metabolic changes associated with clinical ketosis (6, 
247). Subclinical ketosis is difficult to detect visually 
because appetite and activity rate remain normal; however, 
data indicate that subclinically ketotic cows exhibit 
metabolic profiles similar to those of ketotic cows with less 
severe ketonemia and hypoglycemia (8). 
Parturition in cows is a time of severe metabolic and 
nutritional stress. The body tries to adjust by 
repartitioning nutrients so that the mammary gland will have 
adequate nutrients to produce milk. Increased feed intake; 
increased glycogenolysis, ketogenesis, and gluconeogenesis in 
liver; increased lipolysis and decreased lipogenesis in 
adipose tissue; and increased protein mobilization and 
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noncarbohydrate oxidation in muscle are some of the metabolic 
adjustments taking place after parturition. These adjustments 
make more glucose, lipids, and protein available for milk 
synthesis and they normally do not damage the health of cows. 
Lactation ketosis results when there is a lack of systemic 
coordination of the metabolism of carbohydrates, lipids, and 
proteins. 
0verby et al. (182) concluded that time of year, age, and 
individual yield significantly influenced the incidence of 
ketosis. Sarode et al. (199) observed that inadequate 
exercise or stabling of dairy cows and abnormal ruminai 
conditions are some factors responsible for the etiology of 
bovine ketosis. Horber et al. (99) indicated that 
concentrations of ketone bodies (acetoacetate, acetone, and jS-
hydroxy butyrate) in blood, milk, and urine from cows with 
primary ketosis were significantly lower and NEFA 
concentrations were significantly higher than those in healthy 
animals. Valine, leucine, and isoleucine concentrations also 
are elevated in plasma from ketotic cows, and the possibility 
that these amino acids trigger a release of insulin was 
discussed by Kellogg et al. (117). Wu and Thompson (257) 
suggested that ketone bodies can act directly on skeletal 
muscle to decrease the rate of protein synthesis. 
Ketosis has been known to occur spontaneously for no 
obvious reason or as a result of other physiological 
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perturbations, according to Schultz (211) who classified types 
of ketosis as primary and secondary. Unfortunately and in 
spite of elaborate characterization, mechanisms responsible 
for development of primary or secondary ketosis have not been 
elucidated fully. Baird (7, 12) concluded that demands made 
upon milk production at a time of decreased appetite caused 
ketosis, whereas Krebs (124) believed that severe ketosis was 
a result of a breakdown in the mechanisms of carbohydrate and 
lipid homeostasis. In an effort to identify cows that were 
more prone to ketosis, Schultz (209) suggested that some 
causes of ketosis in high-producing cows were increased 
glucose "drain" for lactose production, endocrine disorders, 
hepatic dysfunction, and inadequate energy intake after 
calving. Baird (7) reported that metabolic control mechanisms 
in lactation seem to "push" cows toward carbohydrate 
insufficiency and ketonemia so that adequate milk production 
can be maintained. 
The tremendous stress imposed upon dairy cows by 
selecting for high milk production is increased several fold 
during lactation because of the great demand for glucose 
required for lactose synthesis. The liver tries to meet this 
demand, but it sometimes fails. Then hypoglycemia results. 
The decreased glucose availability in liver sets off a 
cascade, which results in decreased concentrations of glycogen 
and citric acid cycle intermediates, especially oxaloacetate 
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(OAA) and citrate (6). Oxaloacetate is important because it 
is required both as a precursor for glucose and as a part of 
the mechanism for oxidation of acetyl CoA (124). When the 
available OAA decreases, gluconeogenesis will be decreased, 
which subsequently will cause greater formation of ketone 
bodies from fatty acids, when coupled with greater NADH to 
NAD+ ratio. Consequently, insulin decreases, the insulin to 
glucagon ratio decreases, and more NEFA are released from 
adipose tissue, facilitating an increased influx of NEFA into 
the liver (101, 212). In the liver, NEFA can be re-esterified 
and packaged into very-low-density lipoproteins (VLDL) for 
secretion or deposited in the liver as triacylglycerol. These 
NEFA also can be oxidized completely to 00% in the citric acid 
cycle or oxidized incompletely to provide acetyl CoA for 
ketogenesis. Thus, ketonemia also may be caused by increased 
ketogenesis and concurrent hypoinsulinemia (7). 
Kronfeld (126) proposed an alternative theory, 
emphasizing the importance of the ratio of glucogenic to 
lipogenic nutrients. An increased intake of glucogenic 
nutrients would provide substrates for gluconeogenesis and 
also supply precursors for lactose synthesis in the mammary 
gland. However, because glucose does not contribute carbon to 
fatty acids found in milk fat (16), dietary carbohydrate may 
be converted to acetate, which is lipogenic. Kronfeld (126) 
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suggested that a good way to decrease the incidence of ketosis 
would be by adding fat to glucogenic diets. This theory, 
however, fails to account for both the fate of excess lipid 
unused by the mammary gland and the homeostatic controls 
induced by hypoglycemia that are independent of lipid 
availability to the mammary gland. Other theories of ketosis 
development involving carnitine and glucocorticoids have been 
proposed and reviewed (54) but cannot satisfactorily explain 
the etiology of ketosis. 
Hormones also play an important role in the development 
of lactation ketosis. Insulin concentration decreases soon 
after parturition (100), whereas glucagon concentration is 
thought to increase (55). These changes result in a decrease 
in the insulin to glucagon ratio and thereby stimulate 
lipolysis. Glucagon, however, decreases in spontaneously 
ketotic cows and in feed-restricted cows that are ketonemic 
(56). Thus, hypoglycemia and hyperketonemia during ketosis 
seem to be dependent on changes in both of these two hormones. 
Insulin influences mobilization of NEFA from adipose tissue. 
Because insulin is lipogenic and antilipolytic, a decrease in 
insulin will decrease lipogenesis and increase lipolysis from 
adipose tissue (38). Conversely, glucagon is lipolytic and 
consequently can be ketogenic (37). Another important effect 
of glucagon is its influence on the regulation of glucose 
metabolism through acceleration of glycogenolysis and 
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gluconeogenesis in liver. The net effect of these two 
hormones in the cow, therefore, is believed to be dependent on 
their ratio in blood plasma (21). 
Importance of gluconeogenesis in cattle 
Gluconeogenesis in cows is of major importance because 
these animals depend upon it for most of their glucose 
requirements. The liver is the chief organ involved in 
gluconeogenesis (137, 144). At least 90% of the daily glucose 
used by ruminants (5, 266) comes from synthesis by liver and 
kidneys. Otchere et al. (181) quantified a-linked glucose 
polymers passing to the small intestine in growing steers and 
concluded that, even if all the glucose passing to the 
duodenum were absorbed, glucose absorption would contribute 
only 9% of the total glucose metabolized by these animals. 
Glucose can be oxidized completely to 00% through glycolysis 
and the citric acid cycle, yielding ATP molecules through the 
electron transport pathway (226). Gluconeogenesis, therefore, 
makes glucose a readily available source of energy for 
metabolic processes in the body, especially those in the 
nervous system, which includes the brain, and those in the 
fetus. Glucose also can serve as a precursor for (a) glycogen 
in hepatic and muscle cells, (b) glycerol-3-phosphate for 
lipogenesis, and (c) lactose synthesis in the mammary gland 
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during lactation (30). 
Young et al. (262, 263) discussed the activity of 
selected gluconeogenic and lipogenic enzymes in bovine rumen 
mucosa, and rat liver and adipose tissue. Rumen mucosa, 
liver, and adipose tissue contained PEPCK activity. Malic 
enzyme was absent in liver. Citrate cleavage enzyme activity 
was present in liver and adipose tissue but was quite low in 
rumen mucosa. Liver contained much less glucose-6-phosphate 
dehydrogenase activity than did rumen mucosa or adipose 
tissue. 
Young (261) reviewed the significance and methodology of 
gluconeogenesis in cattle. Young et al. (264) studied the 
effects of phlorizin on glucose kinetics in young ruminants. 
Phlorizin did not increase gluconeogenesis in fed ruminants, 
affecting neither pool size nor total entry rate of glucose. 
Young et al. (265) determined parameters of in vivo glucose 
kinetics by single injections and primed-continuous infusions 
of "c-glucose. Parameter variability indicated that 
determination of reliable values requires more kinetic 
experiments than many workers have used and that care must be 
taken in selecting methods for computer analyses of "single 
injection" curves. 
The liver is a complex and essential organ, because it is 
the focal point of carbohydrate, lipid, and protein metabolism 
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that is necessary for normal functioning of other organs. The 
biochemical pathway of glucose synthesis in the liver involves 
reactions both in cytosol and mitochondria. All major 
gluconeogenic compounds except glycerol enter the citric acid 
cycle, which is only present in mitochondria. If citrate 
(formed from OAA and acetyl CoA) is considered the starting 
point of the citric acid cycle, then the end products are CO;, 
NADH, FADHj^ and OAA. Oxaloacetate is important because 1) it 
can either be transported out of the mitochondria in the form 
of malate, which can be reoxidized to OAA via malate 
dehydrogenase for conversion to phosphoenolpyruvate (PEP) in 
the cytosol (13 6, 226), or 2) it can function as an acceptor 
of acetyl CoA to allow complete oxidation of fatty acids and 
carbohydrates to COj(30). Conversion of OAA to PEP via PEPCK 
occurs in cytosol (136). Thus, it is clear how a decrease in 
availability of OAA in mitochondria can decrease 
gluconeogenesis as well as oxidation of fatty acids to CO;. 
There are four reactions that are considered rate-
limiting within the pathways of glucose synthesis: glucose-6-
phosphatase (G6Pase), fructose-1,6-bisphosphatase (FBPase), 
pyruvate carboxylase (PC), and PEPCK (30) . Increased 
activities of both G6Pase and FBPase are needed to drive the 
pathway toward glucose synthesis, G6Pase provides for release 
of free glucose into plasma and activity of PC is essential 
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for the conversion of pyruvate, lactate, and glucogenic amino 
acids to OAA. Because PEPCK catalyzes the conversion of OAA 
to PEP, PEPCK therefore controls gluconeogenesis from all 
physiologically significant glucose precursors except glycerol 
(64). Hence, we can see the importance of PEPCK in 
gluconeogenesis. 
The chief precursors for gluconeogenesis in ruminants are 
propionate, glycerol, lactate, and glucogenic amino acids 
(123). Propionate absorbed from the rumen is considered to be 
the major gluconeogenic precursor in fed ruminants and is the 
only major volatile fatty acid (VFA) produced in the rumen 
that contributes net carbon to gluconeogenesis (245). The 
liver takes up about 90% of absorbed propionate (12, 31). 
After activation to propionyl CoA, carboxylation to 
methylmalonyl CoA, and rearrangement to succinyl CoA, 
propionate then can enter the citric acid cycle as succinyl 
CoA. Acetate is taken up at low rates by the liver, but it 
can only provide acetyl CoA, which does not contribute to the 
net synthesis of OAA or glucose (30). Butyrate can stimulate 
glycogenolysis, which leads to increased glucose 
concentrations in plasma but cannot contribute net carbon for 
carbohydrate synthesis (33). In lactating cows, propionate 
provides for at least 45% of the glucose requirement (252), a 
majority of the remaining propionate is oxidized to CO; in 
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liver (236). It is interesting to note that, although 
propionate is not used entirely for glucose synthesis, 
additional propionate stimulates gluconeogenesis from other 
glucose precursors (53, 236). Wiltrout and Satter (252) 
concluded that increases seen in gluconeogenesis from 
propionate in lactating cows were a result of increased feed 
intake. 
Insulin concentrations in plasma decrease in early 
lactation, resulting in greater rates of lipolysis and a 
significantly greater availability of free glycerol in plasma, 
which can be taken up by liver and converted to glycerol-3-
phosphate, thus entering the gluconeogenic pathway at the step 
before fructose 1,6-diphosphate (136). Plasma glucagon 
increases in early lactating cows, which stimulates protein 
degradation in liver and peripheral tissues and amino acid 
uptake (21). Glycerol constitutes the backbone of 
triacylglycerols in adipose tissues (32), and it is the only 
glucogenic precursor that can form glucose without being 
involved in the citric acid cycle. Data (144, 190) show that 
glycerol can provide for some glucose when other precursors 
are absent. The contribution of glycerol to glucose probably 
will remain low when there is increased lipid mobilization in 
lactating cows, because of the need for glycerol for milk fat 
synthesis. 
Pyruvate is considered gluconeogenic because it is formed 
17 
from lactate (from anaerobic reactions in muscle and rumen) 
and from some amino acids (255). Because lactate may be 
formed from glucose via the Cori cycle, no net synthesis of 
glucose can occur from muscle lactate. Absorbed lactate 
obtained from degradation of carbohydrates in the rumen, 
however, can contribute to net glucose synthesis (145). 
Amino acid contributions to glucose synthesis vary, 
depending upon the physiological and nutritional status (30). 
For example, alanine, serine, and glycine enter the 
gluconeogenic pathway via pyruvate; glutamate and thus 
glutamine enters through a-ketoglutarate of the citric acid 
cycle; and aspartate and thus asparagine enters as OAA. Only 
lysine and leucine contribute no carbon for glucose synthesis. 
Regulation of aluconeoaenesis 
Controls of ruminant gluconeogenesis have been described 
by Bergman (3 0). He indicated that metabolic controls can be 
divided into three categories: substrate supply, enzyme 
activity, and hormonal controls. Regarding substrate supply, 
it is accepted that little glucose is absorbed, that the major 
substrate is propionate, and that gluconeogenic rates are 
greatest after feeding. The second category, enzymatic 
controls, involves the key enzymes of gluconeogenesis, PEPCK, 
G6Pase, PC, and FBPase, which are affected by diet, fasting, 
exercise, pregnancy, and lactation. The enzyme most likely to 
exert primary control of gluconeogenesis in ruminants is PEPCK 
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(148). The third category, hormonal control of 
gluconeogenesis in ruminants, has not been studied 
extensively. 
Experimental induction of ketosis 
Kellogg et al. (116) successfully induced an experimental 
ketosis in lactating dairy cows within 9 weeks postpartum by 
combining thyroxine injections with a low-energy ration. 
Drepper et al. (60) described an induction of ketosis by 
thyroxine in lactating cows. Schlerka and Filar (207) studied 
an experimentally induced ketosis created by administration of 
butyric acid into the rumen, which caused a high ketonemia, a 
metabolic blood acidosis, hemoconcentration, neutrophilia, and 
eosinopenia, as well as decreases of calcium, potassium, and 
sodium ions. Heitzman et al. (92) induced ketosis in six cows 
with above normal blood concentrations of 3-hydroxybutyrate. 
More recently, a successful protocol for inducing ketosis 
by feed restriction and feeding 1,3-butanediol has been 
described (169, 238). A significant decrease in the 
gluconeogenic capacity of liver slices during this 
experimental ketosis was reported by Mills et al. (169). A 
66% decrease in gluconeogenesis from propionate, lactate, and 
several gluconeogenic amino acids suggested that the hepatic 
capacity for gluconeogenesis was regulated at the OAA to PEP 
stage or even later. 
Mills et al. (169) also observed a decrease in 
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concentrations of hepatic citrate during the experimental 
ketosis. Drackley et al. (59) investigated metabolic effects 
of intraruminal administration of 1,3-butanediol or tributyrin 
in lactating goats. Tributyrin, butyric acid, or 1,3-
butanediol greatly increased jS-hydroxybutyrate in blood 
compared with administration of water or glycerol. Because 
1,3-butanediol does not stimulate increases of insulin in 
plasma, it may be more desirable than tributyrin for inducing 
metabolic changes characteristic of lactation ketosis. 
Further research on characterizing changes in gluconeogenic 
capacity and in enzyme activities during "spontaneous on-farm" 
ketosis is needed for better understanding and prevention of 
the problem. 
Treatment of ketosis 
"Prevention is better than cure" goes the old adage; 
indeed, more and more attention is being focused on ketosis 
prevention today. Schultz (211), Baird et al. (10), and 
Hibbitt (94) have provided excellent guidelines for decreasing 
the incidence of ketosis, which are all based upon improved 
feeding of high-producing dairy cows. 
Kuenzle (128) suggested that the primary aim in treatment 
of ketosis is to relieve hypoglycemia. Some of the 
therapeutic measures in use today include intravenous or 
intraperitoneal administration of glucose, oral administration 
of propionate or propylene glycol, and intramuscular injection 
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of glucocorticoids (211). Nicotinic acid also has been 
proposed as a treatment for ketosis because of its 
antilipolytic properties and its ability to increase insulin 
concentrations (241). Dietary supplementation of niacin to 
clinically and subclinically ketotic cows caused cows to 
produce slightly more milk (62, 70), increased glucose in 
plasma, and decreased jS-hydroxybutyrate and free fatty acids 
in plasma. Goranov et al. (77) demonstrated that prophylactic 
use of monensin and nicotinic acid in cows with subclinical 
ketosis decreased the manifestations of hypoglycemia and 
ketonuria to a minimum. 
Treatment of ketotic cows with a combination of sodium 
propionate, glycerol, and propylene glycol in moderate doses 
has been discussed (183, 184). Propionate administration 
provides a gluconeogenic precursor that stimulates 
gluconeogenesis and thereby increases glucose released by the 
liver. Fisher et al. (67) observed that supplementation with 
propylene glycol seemed to increase milk yield by 3 to 6% and 
caused a slight decrease in milk fat and an increase in milk 
lactose percentages. Goranov et al. (78) found that a 
preparation containing propylene glycol, methionine, and 
cobalt dichloride was beneficial in prevention or treatment of 
ketosis when given orally to sheep and cows. Ruegsegger and 
Schultz (198) used a combination of propylene glycol and 
niacin for treating subclinical ketosis, which reinforced the 
21 
concept that optimal feeding and management decreases the need 
for use of additives to control ketosis. 
Jonsgard et al. (114) observed therapeutic effects of 
both prednisone and betamethasone on treatment of ketosis. 
Wierda et al. (250) evaluated the effects of two 
glucocorticoid derivatives (Dexamedium and Ingelheim) on 
healthy and ketotic cows. Both compounds caused an increased 
concentration of blood glucose and a temporary decrease in 
milk yield of healthy cows. Reynaert and Peeters (193) 
suggested that a decrease in growth hormone might benefit 
ketotic cows. 
Although monensin, which increases the production of 
propionate in the rumen fermentation, might have some 
undesirable effects on milk composition, Rogers (196) 
described the use of monensin sodium in control and prevention 
of ketosis in dairy cows fed poor quality silage. Sauer et 
al. (203) discussed the antiketogenic effects of monensin in 
early lactation. Glucose administration provides an immediate 
source of glucose, which alleviates hypoglycemia and increases 
carbohydrate sufficiency. Administration of glucose into 
blood, however, actually decreases hepatic gluconeogenesis in 
normal, lactating cows (12). 
Schafer et al. (206) used Osimol® (a preparation 
containing sodium propionate, citric acid, and some trace 
mineral elements) for prophylaxis and therapy of ketosis in 
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dairy cows. Shmuilovich et al. (215) suggested that ketosis 
could be treated with a sodium j8-hydroxybutyrate preparation. 
Stoikov (225) administered DL-methionine orally for 
prophylaxis and treatment of ketosis in high-producing cows. 
Concentrations of glucose, ketone bodies, total lipids, total 
protein, bilirubin, serum glutamic oxaloacetic transaminase, 
serum glutamic pyruvic transaminase, lactate dehydrogenase, 
and aldolase in blood were influenced positively by the 
administration of methionine. 
Fox (69) discussed the clinical diagnosis and treatment 
of ketosis. Lilja (141) estimated the therapeutic effect of 
parenteral iron-dextran treatment in ketotic dairy cows. This 
treatment did not change the hematocrit or the hemoglobin 
concentrations significantly during the experimental period; 
but, the hyperketonemia and hyperglycemia were eliminated in 4 
d and the increased concentrations of NEFA were decreased 
significantly. 0rskov et al. (180) studied the possibility of 
increasing milk yield by stimulating fat mobilization through 
feeding undegraded protein supplements to underfed cows in 
early lactation. 
Biochemical indices of ketosis 
Tenca et al. (228) emphasized the possibilities of early 
diagnosis of ketosis by serum electrophoretic analysis of 
blood proteins. Crohn (79) observed an increased propionate 
utilization by the liver in spontaneously ketotic dairy cows. 
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resulting in an increase in blood glucose concentrations and a 
decrease in acetoacetate and /3-hydroxybutyrate concentrations. 
Herdt et al. (93) concluded that the logarithmic means of 
blood /S-hydroxybutyrate concentrations may be of greater value 
than are arithmetic means of plasma glucose concentrations for 
the prediction of prevalence of ketosis in herds. 
Peichev (185) observed that reproductive functions were 
disturbed in cows with ketosis, and cases of difficult 
calving, placenta retention, and acute endometritis were more 
frequent than in cows not affected by ketosis. Peneva and 
Goranov (186) observed changes in some serum enzymes and in 
clinical and biochemical indices in cows with subclinical 
ketosis. Schafer and Schwarzer (205) studied clinical 
diagnosis of ketosis in herds of dairy cows. On the basis of 
their data, ketone body concentration in blood was suggested 
to be a tool for diagnosis or assessment of the metabolic 
situation in a herd. 
Biochemical studies on serum of cows affected by ketosis 
have been conducted by many investigators (129, 161, 219, 220, 
221). Variations in values of serum glutamic pyruvic 
transaminase, alkaline phosphatase, and acid phosphatase have 
no definite diagnostic value in establishing the lesions in 
the liver of cows affected by ketosis. Simeonov et al. (222) 
concluded that ketosis had affected unfavorably the normal 
course of the parturition process and the conception rates of 
24 
high-producing cows. Steger et al. (224) evaluated the stage 
of ketosis in lactating cows by estimating concentrations of 
ketones in blood and of acetone in milk. They concluded that 
determination of the acetone concentration in milk would 
provide conclusive evidence for the presence of a subclinical 
state of ketosis. Furthermore, assay of acetone concentration 
in milk is much more practical than the laborious chemical 
method for determining the concentration of total ketone 
bodies in blood. 
Vassilev (234, 235) observed an increase in 
concentrations of total bilirubin and total lipids and a 
decrease in cholesterol in the serum of cows affected with 
ketosis. Waterman and Schultz (239) demonstrated that 
percentages of C14:0 and C16;0 fatty acids in milk fat 
increased following treatment of bovine ketosis with nicotinic 
acid, whereas percentages of C18:0 fatty acid decreased. 
Waterman et al. (241) also observed that NEFA, glucose, and 
ketone bodies, as well as appetite, returned to normal within 
21 d of treatment with nicotinic acid. 
In another study, Waterman and Schultz (240) observed 
that treatment of bovine ketosis with methionine hydroxy 
analog caused slow increases of blood glucose, 
triacylglycerol, cholesterol ester, free cholesterol, and 
phospholipid in plasma and a slow decrease of acetate. Morrow 
(170) discussed the fat cow syndrome. Histological changes in 
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the liver, kidney, and heart of cows with the syndrome 
included extensive fatty infiltration (171). 
Lyle et al. (149) studied kinetics of glucose metabolism, 
plasma metabolite concentrations, and endocrine responses 
during an experimental ketonemia in steers. Phlorizin plus 
1,3-butanediol was used to cause glucosuria and ketonuria, 
decreased plasma glucose, and increased blood ketone bodies, 
plasma free fatty acids, glucose irreversible loss, and 
glucose pool size. Growth hormone, insulin, and glucagon in 
plasma were not affected (193, 250). 
In another study, Lyle et al. (150) studied plasma and 
liver metabolites and glucose kinetics in steers as affected 
by prolonged ketonemia, glucosuria and fasting. Steers given 
1,3-butanediol plus phlorizin did not show all the usual signs 
of clinical ketosis, but the treatment used to attempt to 
induce clinical ketosis possibly can be used to study some 
causes and effects of ketosis. Lyle et al. (151) also 
demonstrated that the gluconeogenic capacity of bovine liver 
was responsive to physiological and nutritional status. 
Veenhuizen et al. (237) determined the effects of injecting 
phlorizin subcutaneously and feeding propionate on metabolism 
of glucose, propionate, and 00%. The percentage of propionate 
converted to plasma glucose and to blood and rumen CO^ was not 
affected by feeding propionate. 
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Scott et al. (213) discussed the inability of mammary 
tissue from lactating cows to convert gluconeogenic substrates 
to glucose, the virtual absence of G6Pase, and the lack of 
excess gluconeogenic substrates 'available to the intact 
mammary gland of lactating cows. Desco et al. (57) analyzed 
several biochemical parameters (urea, glucose, cholesterol, 
lipids, bilirubin, uric acid, and creatinine) in blood of 
sheep and justified the use of sheep and cows as good models 
for research in ketosis. 
II. PEPCK 
Phosphoenolpyruvate carboxykinase (GTP:oxaloacetate-
carboxylase (transphosphorylating): EC 4.1.1.32), or PEPCK, 
often has been identified as the key rate-limiting enzyme in 
the series of gluconeogenic reactions leading from 
dicarboxylie acids to glucose. PEPCK was identified first in 
chicken liver (232, 233). Since then, it has been purified 
from a number of organisms including both vertebrates (14, 42, 
89, 201) and invertebrates (51, 197, 230, 251). PEPCK 
catalyzes the reversible reaction: 
PEP + CO; + NOP « > OAA + NTP 
The PEPCK reaction has been well characterized (89, 90, 
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197, 208). In the direction of OAA formation, PEPCK requires 
a nucleotide diphosphate (NOP). PEPCK from most organisms 
utilizes either IDP or GDP. Only bacteria and plant PEPCK 
have been reported to be active with ADP (231). Metal ion 
requirements seem to be limited to divalent cations, with Mn^+ 
and Mg^"*" being the most common metal activators. Activation by 
Zn^"*", Co^+, and Cd^"*" also has been reported (18, 68), and 
Karczmarewicz and Lorenc (115) observed that rat PEPCK was 
inhibited by Ca^ "^ . 
Distribution of PEPCK 
As a key enzyme of gluconeogenesis in vertebrates, PEPCK 
is found predominantly in gluconeogenic tissues, mainly liver 
and kidney. The intracellular distribution of PEPCK varies 
widely among species of animals (86, 176). Rats contain about 
90% of PEPCK in cytosol and 10% in mitochondria; species such 
as guinea pigs, sheep, dogs, cats, and humans contain 60% in 
mitochondria and 40% in cytosol. Avian species contain PEPCK 
only in mitochondria. It has been observed (4, 223) that, 
although mitochondrial PEPCK is important in specific 
metabolic processes such as hepatic gluconeogenesis, it is not 
inducible to the same extent as is cytosolic PEPCK. In guinea 
pig and rabbit livers, both cytosolic and mitochondrial forms 
of PEPCK function during gluconeogenesis from lactate and 
alanine. 
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Regulation of gluconeogenesis in species containing 
mitochondrial activity of PEPCK is significantly different 
from regulation operating in rat liver and reflects to a large 
extent the compartmentation of PEPCK (4). The cytosolic form 
of the enzyme is not present in liver of fetal rats in utero. 
PEPCK also is found in intestinal mucosa, mammary gland, and 
adipose tissue. Hedeskov et al. (91) demonstrated PEPCK 
activity in mouse pancreatic islet cytosol. The enzyme 
appears for the first time at birth (13, 72, 87) as a result 
of initiation of PEPCK synthesis. Girard (75) felt that the 
rise in plasma glucagon and the fall in plasma insulin that 
occur immediately after birth are the main determinants of the 
appearance of liver PEPCK (GTP) in rats. 
PEPCK in liver 
Gluconeogenesis seemed to be localized in periportal 
hepatocytes, whereas glycolysis was found to be more active in 
cells surrounding the pericentral liver cells (1, 80). For 
male and female rats, Wimmer et al. (254) observed increased 
PEPCK activity in the perivenous zone within the liver acinus 
when compared with the periportal zone. Hepatic enzyme 
synthesis is enhanced rapidly by glucagon and epinephrine 
(109, 138, 248). Synthesis of PEPCK in the cytosol of rat 
liver is regulated by cAMP and insulin as well as by 
glucocorticoids. Nuclear factors necessary for cAMP induction 
of transcription of the PEPCK gene are conserved between 
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tissues and species (35) . 
Several models have been proposed for regulation of 
hepatic PEPCK by insulin and glucagon. Meisner et al. (163) 
proposed a model for stimulation of PEPCK mRNA synthesis by 
cAMP, which is based on the rapidity and magnitude with which 
the gene coding for cytoplasmic PEPCK in hepatic tissue 
responds to intracellular cAMP concentration. Injection of 
dibutyryl cAMP, glucagon, or epinephrine causes premature 
appearance of the enzyme in livers of fetal rats in utero 
(48), but elevated rates of enzyme synthesis return to basal 
levels within 3 hours (22). Insulin decreases production of 
PEPCK mRNA (23), but it does not alter the activity of a fixed 
amount of this RNA or enhance its degradation (24, 49). 
Christ et al. (45) concluded that glucagon-dependent induction 
of PEPCK was modulated by the local hormone adenosine via a 
mechanism not involving adenylate cyclase and by acetoacetate 
via an unknown mechanism. 
Gunn et al. (85) showed that hormonal regulation of PEPCK 
activity in vivo results from changes in the rate of enzyme 
synthesis. Seitz et al. (214) concluded that glucagon 
regulates PEPCK activity physiologically by decreasing the 
intrahepatic cAMP concentration rather than by the postulated 
cAMP-independent inhibition of specific mRNA translation, 
lynedjian et al. (110) observed that glucagon stimulated the 
rate of synthesis of PEPCK by four to six fold; changes in 
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rates of synthesis were accounted for totally by Increases In 
amounts of corresponding functional mRNA, suggesting that 
glucagon acted at a pretranslational site. Gunn et. al. (83, 
84) used immunochemical techniques to study effects of 
glucocorticoids on synthesis and degradation of PEPCK in rat 
liver and kidney in vivo. Their results suggested that 
hepatic PEPCK activity is regulated predominantly by the 
antagonistic interaction of cAMP (glucagon) and insulin on 
enzyme synthesis. Christ et al. (46) proposed that the 
destabilizing activities of PEPCK mRNA were induced rapidly de 
novo by insulin as an antagonistic principle and slowly by 
glucagon as a self-regulated shut-off mechanism. 
It is possible that amounts of PEPCK mRNA can be 
controlled at transcription (i.e., at processing of immature 
mRNA) or at translation via stabilization of the mRNA against 
degradation (130). Faliks et al. (65) observed that PEPCK 
mRNA decays rapidly. They suggested that a general 
inactivating system of mRNA that turns over rapidly may be 
present in rat liver. The system may involve a peptide factor 
because protein synthesis inhibitors block it. Regulation of 
this system or factor might be of great significance in 
regulating translatable mRNAs in cells. 
lynedjian and Salavert (108) provided indirect evidence 
for a primary effect of glucocorticoids on expression of the 
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PEPCK gene and suggested that dexamethasone and T, played a 
role as physiological modulators of PEPCK expression. 
lynedjian and Hanson (104) showed that glucocorticoid 
administration and acidosis cause additive increases in 
amounts of translatable PEPCK mRNA, possibly through a 
stimulation of enzyme synthesis. Chu et al. (47) concluded 
that the PEPCK gene was significantly more sensitive to low 
concentrations of insulin, which reciprocally regulates 
transcription of the gene. 
Bartels et al. (19) indicated that PEPCK activity and 
enzyme protein were regulated mainly at the pretranslational 
stage. Sasaki et al. (200) suggested that the primary action 
of insulin in the regulation of PEPCK synthesis is exerted at 
the level of transcription of PEPCK mRNA. Lobato et al. (147) 
observed that PEPCK activity in mammary gland as well as in 
liver is coordinately regulated by prolactin, glucocorticoids, 
and insulin. Andreone et al. (3) believed that insulin 
regulates PEPCK synthesis through a receptor-mediated process. 
The effect occurs when less than 2% of insulin receptors are 
occupied, and it is exerted before mRNA translation. 
Induction of hepatic PEPCK by cAMP is characterized by a rapid 
buildup of newly synthesized, actively translated mRNA coding 
for the enzyme. This messenger accumulation could be the 
result of an increase in rate of production or a decrease in 
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rate of degradation. 
According to Kioussis et al. (118), changes in PEPCK mRNA 
closely parallel changes in PEPCK synthesis found under the 
same conditions and suggests that the amount of specific mRNA 
in the liver determines the extent of synthesis of PEPCK. The 
half life of PEPCK mRNA is about 40 minutes, which is very 
short (172). 
Several studies have been performed on chicken liver 
PEPCK. Watford (242) observed that functional activity of 
cytosolic PEPCK is not detected in the liver of starved 
chickens despite considerable amounts of mRNA for PEPCK. This 
observation indicates some form of posttranscriptional 
regulation. Bannister and O'Neill (17) showed that PEPCK was 
located almost exclusively within the mitochondria of 
chickens. Administration of cAMP to chickens caused a rapid 
induction of mRNA for cytosolic PEPCK, thus showing that the 
gene for the cytosolic form of PEPCK in chicken liver can be 
expressed in the presence of proper hormonal stimuli (95, 97, 
98). Moreover, Guidinger and Nowak (81) observed that PEPCK 
from mitochondria of chicken liver shows a remarkably high 
degree of specificity at the binding site for OAA. 
Ogata et al. (178) observed that the mitochondrial 
location of PEPCK in chicken liver influences the pattern of 
regulation of gluconeogenesis and ketogenesis in this species. 
Hebda and Nowak (90) purified PEPCK from chicken liver 
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mitochondria and described the requirement of a thiol for 
maximal activity, although apparently not to reduce disulfide 
bonds within the enzyme. Sato et al. (201) purified and 
characterized cytosol-specific PEPCK from chicken liver. The 
purified enzyme had a molecular weight of 68,000 daltons. 
Specific activities of the cytosolic enzyme were 30 to 100% 
higher than those for the mitochondrial enzyme from chicken 
liver; however, the fundamental catalytic properties were 
similar, despite a marked difference in amino acid 
compositions. 
Gallwitz et al. (71) described procedures for 
purification of mitochondrial and cytosolic isozymes of PEPCK 
from rabbit liver, which indicated apparent homogeneity and 
identical molecular weights of 65,000. Differences in 
sequences were found throughout primary structures of 
isozymes. Satoh (202) observed that mitochondrial PEPCK (GTP) 
purified from liver of chick embryos was activated 
synergistica 1 ly by a combination of Mn^"*" and Mg^"^. These 
results suggested that Mn^+ can play two roles: it can either 
activate or suppress PEPCK activity in the presence of high 
concentrations of Mg^ "*". 
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PEPCK in kidney 
Synthesis of renal PEPCK is enhanced by glucocorticoids 
and metabolic acidosis. Dibutyryl cAMP and insulin do not 
affect synthesis of the renal enzyme directly, but alkalosis 
decreases the rate of renal PEPCK synthesis, which causes a 
return to basal levels. It is still not well understood how 
alterations in the acid-base status of rats change renal PEPCK 
synthesis rates (109). Watford (243) suggested that in 
chickens the kidney is the major site of gluconeogenesis from 
substrates other than lactate, and thus gluconeogenesis plays 
an important role in maintenance of glucose homeostasis. 
Watford and Mayes (244) concluded that acidosis, 
glucocorticoids, and cAMP independently regulate expression 
of renal PEPCK. 
Renal PEPCK is immunochemically identical to hepatic 
PEPCK, but it is regulated differently. Bogusky et al. (34) 
observed that metabolic acidosis in rats causes increased 
formation of NH3 and glucose by the kidney, and they postulated 
that PEPCK augmented both gluconeogenesis and ammoniagenesis 
and regulated OAA concentrations in kidney. Transcription 
rates of the gene for PEPCK in rat liver and kidney respond to 
hormones in a tissue-specific manner (164). lynedjian and 
Peters (107) concluded that metabolic acidosis develops early 
in starved rats and could be the cause of renal PEPCK 
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induction and gluconeogenesis stimulation. Garcia-Salguero 
and Lupianez (74) observed that PEPCK and FBPase activities 
parallel each other, but they are regulated differently in 
renal gluconeogenesis. 
PEPCK in adipose tissue 
PEPCK also is found in adipose tissue, but its activity 
is about one-tenth that of liver (192). PEPCK activity in 
adipose tissue is stimulated by starvation and decreased when 
animals are refed a carbohydrate-rich diet. Insulin and 
glucocorticoids regulate adipose tissue PEPCK (i.e., decrease 
its synthesis) by different mechanisms (83, 167). Meyuhas and 
coworkers (166) showed that repression of adipose tissue PEPCK 
(GTP) is regulated independently by glucocorticoids and 
insulin by decreasing the rate of synthesis. Although PEPCK 
(GTP) in liver, kidney, and adipose tissue is seemingly 
identical, there is an apparent tissue-specific 
differentiation in regulatory systems. Feldman and Hirst (66) 
demonstrated differences in PEPCK regulation between brown and 
white adipose tissue, and the response to glucocorticoids was 
unique in brown adipose tissue. 
PEPCK in mammary aland 
Garcia-Ruiz et al. (73) measured PEPCK activity in 
mammary gland and liver of rats at all stages of the 
reproductive cycle. Different patterns of PEPCK activity were 
obtained in liver and mammary gland during the lactation 
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cycle. Weaning mid-lactation rats for 48 h resulted in an 
abrupt decline in PEPCK activity in mammary gland, but there 
was only a small decrease in liver. Activity of PEPCK 
correlated inversely with plasma insulin concentrations 
reported for the lactogenic process. Baird (9) indicated 
that the presence of both FBPase and PEPCK in lactating bovine 
mammary gland suggested that, carbohydrate synthesis takes 
place in this tissue from the level of the citric acid cycle. 
One function of a gluconeogenic pathway in the bovine mammary 
gland could be that of synthesizing lactose from 
noncarbohydrate precursors circulated in the blood. 
Jones et al. (113) measured PEPCK activity in guinea pig 
mammary gland throughout the pregnancy-lactation cycle. The 
PEPCK activity, present in both cytosol and mitochondria, was 
shown to follow the lactation profile. Mitochondrial PEPCK 
showed a greater increase during the transition into 
lactation, thus seeming to play a more important role in 
conversion of OAA to PEP in mammary tissue. 
Scott et al. (213) investigated the gluconeogenic 
capacity of mammary tissue of lactating cows by incubating 
mammary tissue slices with alanine, glutamate, lactate, 
pyruvate, or glycerol in conjunction with acetate and glucose. 
The inability of cow mammary tissue to convert gluconeogenic 
metabolites to glucose is consistent with the virtual absence 
of G6Pase and the lack of excess gluconeogenic substrates 
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available to the intact mammary gland of lactating cows. 
PEPCK mRNA turns over very rapidly if the pathway for 
synthesis of new mRNA is blocked. It seems likely that cAMP 
alters concentrations of PEPCK mRNA by acting at either 
transcription or processing of mRNA (172). 
Kinetics and regulation of PEPCK activity 
Several studies have been conducted on cofactor binding 
requirements of PEPCK in mammals. MacDonald (152) 
hypothesized that Fe^"*" and 3-mercaptopicolinic acid (3-MPA) 
form a coordination complex that inhibits the carboxykinases 
and that 3-MPA does not bind to a carboxykinase containing 
Mn^'*'. Hebda and Nowak (89) observed differences in the active 
site structures of PEPCK from pig liver, sheep kidney 
mitochondria, and chicken liver mitochondria. Merryfield and 
Lardy (165) observed that streptonigrin, an antibiotic with 
anti-neoplastic activity, inhibited rat liver PEPCK with an Ijg 
of 0.3 /iM when excess FeClj was present. Lewis et al. (140) 
indicated that PEPCK from the cytosol of rat liver has 13 
cysteines. The cysteine residue at position 288 is known to 
be very reactive and essential for catalytic activity, 
possibly because it lies between two putative phosphoryl 
binding domains and within a hydrophobic sequence. 
Schramm et al. (208) concluded that metal binding sites 
for the Mg^"*" of the Mg-GTP complex and for free Mn^"*" are found 
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on PEPCK of rat liver cytosol. This PEPCK then is sensitive 
to Mn^* activation. The major effect of Mn^"*" activation is to 
increase the of product formation. Substrates for 
mitochondrial PEPCK from guinea pig liver include IDP, GDP, 
and XDP. These substrates all have a keto group at C-6 and an 
NH group at N-1 of the pyrimidine ring, suggesting that these 
sites are essential for enzyme-substrate interactions (20). 
Brinkworth et al. (36) observed, under conditions where GTP is 
present as the Mg-GTP complex and free Mg^+ is present in 
excess, that Mn^"*" activation of PEPCK depends upon the degree 
of oxidation of cysteine sulfhydryls for PEPCK from rat liver 
cytosol. 
Duffy et al. (61) observed an active site homology for 
all carboxykinases, with mitochondrial PEPCK being more 
susceptible to inhibition than the cytosolic enzyme in guinea 
pigs, monkeys, rats, and chickens. This difference suggests 
that slight differences in ligand interactions may be present 
at the active sites. Jomain-Baum et al. (112) suggested that 
3-MPA, a hypoglycemic agent, inhibits gluconeogenesis from 
lactate by isolated, perfused livers from fasted rats and 
guinea pigs by removing a tightly bound, rapidly exchanging 
metal ion other than Mn^ "*". 
Kostos et. al. (121) observed that in rat and guinea pig 
tissues in vitro 3-MPA inhibited PEPCK activity in vitro in 
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rat and guinea pig tissues and seemed to be noncompetitive 
with respect to Mn^"*". Jomain-Baum and Schramm (111), by virtue 
of their complete product inhibition study with Mn-GDP", PEP, 
and HCO3. as product inhibitors of PEPCK (GTP) from rat liver 
cytosol, indicated that all kinetic patterns were 
noncompetitive. Konopka et al. (120) observed that rat liver 
cytosolic PEPCK utilizes inosine 5'-(3-thiotriphosphate) as a 
substrate, but the reaction mechanism does not involve a 
phosphoryl enzyme intermediate. 
Makinen and Nowak (158) observed that inhibition of 
chicken liver PEPCK by 3-MPA involved a conformational change 
in the enzyme, but the change did not increase thermostability 
of the ternary complex. Inhibition by 3-MPA is the result of 
specific and reversible binding within the active site of 
PEPCK. Lee and Nowak (132) observed that Mn^"*" increases the 
affinity of PEPCK for the nucleotide. 
Lee et al. (134) observed a strict geometric specificity 
of the nucleotide substrate at the ^ -position with the 
interaction of the ^ -phosphate with the enzyme and with a 
metal ion. Lewis et al. (139) observed that photo-
inactivation of PEPCK by 8-azido-GTP is caused by formation of 
an intramolecular cystine disulfide bridge, thus providing 
evidence for a pair of proximal cysteine residues within the 
GTP-binding site. Maxwell and Ray (160) observed that PEPCK 
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is not activated by Fe^"^ but is inhibited by quinolinate 
whether or not Fe^"*" is present. 
Silverstein et al. (218) studied inactivation and 
modification of PEPCK labeled differentially with 
bromopyruvate. It seemed that a common sulfhydryl was 
critical to both carboxykinase and oxalacetate decarboxylase 
activities and that each activity utilized the same nucleotide 
binding site, despite different known roles of the inosine 
nucleotide in each reaction. 
Studies of PEPCK in birds have been revealing. Cheng and 
Nowak (43) labeled PEPCK in the absence of CO; and indicated 
that avian PEPCK has two or three reactive arginine residues 
out of a total of 52, and only one or two of the arginines are 
located at the active site and involved in CO; binding and 
activation. Lee et al. (133) suggested that activation by 
micromolar amounts of Mn^"^ at millimolar concentrations of 
Mg^"^; hence, the rate of gluconeogenesis can be modulated by 
changes in concentration of Mn^+ within mitochondria. Cheng 
and Nowak (44) observed that avian PEPCK has two histidine 
residues that are reactive with diethylpyrocarbonate and 
dimethylpyrocarbonate. One of the 15 histidine residues in 
the PEPCK is at or near the binding site and is involved in 
catalysis. Makinen and Nowak (159) observed that modification 
of avian PEPCK by a variety of sulfydryl reagents leads to 
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inhibition. Kramer and Nowak (122) observed that, enzyme 
activity is stimulated 200 to 250% by Cr(H20)4GTP when the 
substrate for avian PEPCK is Mn-GTP at 0.2 mM (pH 8.0). This 
effect is probably caused by interaction of PEPCK with 
Cr(H20)4GTP, producing a "memory effect" that is manifested 
with guanosine nucleotide substrates but that is not observed 
with the alternative substrate, Mn-ITP. 
Newsholme and Williams (174) observed that muscle PEPCK 
is involved in oxidation or conversion of some amino acids to 
alanine. Opie and Newsholme (179) suggested that the presence 
of FBPase and PEPCK in white muscle may be related to 
operation of the a-glycerophosphate-dihydroxyacetone phosphate 
and malate-oxaloacetate interconversions in this tissue. 
lynedjian (103) observed that PEPCK migrates as a single 
protein of molecular weight 70,600 during electrophoresis on 
sodium dodecyl sulfate polyacrylamide gels. Cannata and de 
Flombaum (39) observed that PEPCK from baker's yeast shows a 
pH optimum at 8.3 with Mn^"^ as the cation. They propose at 
least two binding sites related to cation requirement on the 
yeast enzyme, with one site binding a cation-nucleotide 
complex, the true substrate, and the other site binding a free 
divalent cation. Binding of free cation at the latter site 
greatly enhances affinity of the former site for the cation-
nucleotide substrate. Only Mn^"^ and Cd^^ seem to be able to 
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fulfill the requirement for a free divalent cation. 
PEPCK from vertebrate tissues is sensitive to thiol 
reagents, and free sulfhydryl groups are essential for 
catalytic activity. Malebran and Cardemil (157) observed that 
PEPCK from Saccharomvces cerevisiae is inactivated completely 
by phenylglyoxal and 2,3-butanedione in borate. The enzyme 
can be protected against inactivation by PEP, ADP, and Mn^* 
(alone or in combination), suggesting that the modification 
occurs at or near the substrate-binding site. 
Administration of tryptophan in the diet of rats led to a 
specific inhibition of the gluconeogenic pathway at the PEPCK 
reaction (191). Foster et al. (68) demonstrated that Mg^* 
functions in a complex with the nucleoside triphosphate 
substrate. Quinolinate produced in liver cells from rats 
administered tryptophan obtains Fe^+ from some reservoir and 
forms a 2:1 complex (153) that inhibits PEPCK in vivo. Bentle 
and Lardy (26) purified the PEPCK ferroactivator from rat 
liver cytosol to apparent homogeneity. This ferroactivator is 
a protein of about 90,000 daltons and is comprised of four 
apparently identical subunits of 22,500 daltons, which permits 
ferrous ions to activate PEPCK two-fold or more. The 
ferroactivator is present in the cytosol of liver and kidney 
of all species and will stimulate cytosolic PEPCK in the 
presence of Fe^"*", but it has no effect on mitochondrial PEPCK 
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(155) . 
PEPCK has 13 thiols per 72,000 daltons, and six of these 
form three pairs of vicinal dithiols that are converted 
readily to disulfides (41). PEPCK can be activated by Mn^+, 
but not by Fe^+ unless ferroactivator is present. PEPCK, like 
other kinases, is probably a bilobular enzyme with its 
catalytic site at the base of the groove (2) . Possibly Fe^ "^  
cannot get to the normal binding site for its catalytic 
function because it is blocked by thiols that line the channel 
formed by the two lobes. Quinolinic acid, 3-aminopicolinic 
acid (3-APA), or ferroactivator possibly could combine with 
four of the coordination positions of Fe^+ and allow Fe^+ to 
slip past the highly reactive thiols. Because thiols do not 
bind Mn^"^ as avidly as they bind Fe^+, the former could 
possibly reach the catalytic site without difficulty. 
Because of its structural similarity to quinolinic acid, 
3-APA was tested as a possible activator of PEPCK. Like the 
ferroactivator protein, 3-APA activated PEPCK at moderate Fe^* 
concentrations, never in the absence of Fe^+, and it alleviated 
inhibitory effects of high concentrations of Fe^+ (154, 156). 
Ballard and Hopgood (15) suggested that the initial step in 
the degradation of PEPCK (GTP) is an inactivation reaction, 
perhaps involving oxidized thiol compounds. 
Cycloheximide stabilizes PEPCK mRNA when used at 
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concentrations that abolish protein synthesis; at these 
concentrations, PEPCK is protected even from cordycepin. The 
effect of cycloheximide is not caused by inhibition of protein 
synthesis. Hence, the stabilizing effect of cycloheximide 
must be the result of translation. PEPCK synthesis is 
regulated selectively by cAMP in liver of fasted rats. Other 
tissues do not respond similarly to cAMP, but they are 
regulated by direct metabolic stimuli such as acid-base 
changes (173) . 
Lardy et al. (131) discussed the hormonal activation of 
cytosolic hepatic PEPCK to enhance gluconeogenesis. Receptors 
for peptide hormones, vasopressin, and angiotensin, as well as 
catecholamines, epinephrine, and norepinephrine, are contained 
in plasma membranes of parenchymal cells. These receptors 
are activated by specific agonists that interact with 
mitochondria. The activation may occur through a second 
messenger, which causes mitochondria to release Ca^"*". The 
resulting increased cytosolic Ca^"*" concentration somehow causes 
Fe^"*" to be released from a mitochondrial pool into the cytosol. 
The Fe^+ that is released probably is chelated by the 
ferroactivator protein and inserted into its catalytic binding 
site on PEPCK. This binding activates the enzyme, which 
remains activated until other cellular events deprive it of 
Fe^ "*" either by competitive binding or by oxidizing it to Fe^ "*". 
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Noce and Utter (175) concluded that pyruvate formation is 
very unlikely to proceed via PEP as an intermediate. Utter 
and Kurahashi (232) suggested that PEP may be formed from a 
pathway involving dicarboxylic acids. Studies of PEPCK 
reaction mechanisms by Hebda and Nowak (89, 90) have suggested 
that PEP binds to the active site via a divalent metal cation, 
most likely Mn^"*". Carbon dioxide binds directly to the active 
site. The nucleotide diphosphate seems to enter the active 
site as a complex with another divalent metal cation. 
Molecular advances in PEPCK 
Several investigators have studied molecular genetic 
aspects of PEPCK. Hatzoglou et al. (88) proposed a pathway 
for processing of PEPCK RNA that involved splicing of introns 
starting at the 5' end of the RNA transcript and proceeding 
toward the 3' end. lynedjian and Hanson (105) partially 
purified the mRNA that codes for PEPCK (GTP) from the liver of 
rats treated with cAMP. The mRNA for PEPCK seemed to have a 
leap' at the 5' end. lynedjian and Jacot (106) suggested 
that, in rat kidney, a glucocorticoid responsive domain for 
several distinct proteins existed in the mRNA for PEPCK. Lee 
et al. (135) tested nuclear extracts prepared from rat livers 
and detected an element that confers transcriptional 
regulation by cAMP. 
Benvenisty et al. (28) observed that separate cis-
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regulatory elements confer cell-specific expression of the 
PEPCK gene. Donner et al. (58) observed that PEPCK (GTP) was 
not expressed if deletions were present in chromosome seven of 
the mouse. Wynshaw-Boris et al. (258) localized the cAMP 
responsive sequences of the PEPCK gene to its 5'-end and are 
mapping the location of these cAMP responsive sequences. 
Wynshaw-Boris et al. (259) showed, in addition to a cAMP 
regulatory element located at the 5' end of the PEPCK gene, 
the presence of a glucocorticoid regulatory element. They 
also discussed techniques for determining sequence 
requirements for hormonal regulation of gene transcription by 
using rat cytosolic PEPCK gene as a model (260). 
Linking the PEPCK promoter to a reporter gene to study 
liver-specific activation of the PEPCK gene of rats has been 
done. Benvenisty et al. (28) showed an increased expression 
of the PEPCK-chimeric construct by rat liver mRNA. Lim et. 
al. (142) found that retroviral gene transfer of PEPCK O*-
alkyIguanine-DNA-alkyltransferase (ada) chimeric gene allowed 
efficient and inducible expression of ada, which may be used 
to study the role of alkyltransferase in repair of mutagenic 
DNA lesions in mammalian cells in vivo. McGrane et al. (162) 
studied the tissue specific expression and dietary regulation 
of a chimeric PEPCK/bovine growth hormone gene in transgenic 
mice. They concluded that the region between -460 and +73 in 
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the PEPCK promoter-regulatory region probably contains 
sequences that can direct tissue-specific expression and 
hormonal and dietary responsiveness of a linked structural 
gene. Lim et. al. (143) observed that the PEPCK promoter is 
induced by hormones, which results in gene expression in liver 
and kidney. 
Wieghart et al. (249) studied PEPCK gene expression in 
transgenic pigs harboring a rat PEPCK/bovine GH fusion gene. 
In terms of tissue and developmental specificity, PEPCK gene 
expression seems similar to that observed in PEPCK/bGH 
transgenic mice. Petersen et al. (187) constructed chimeric 
genes and demonstrated that two widely separated enhancer-like 
elements contribute equally to the response of the PEPCK gene 
to glucocorticoid hormones. Petersen et al. (188) concluded 
that stabilization of PEPCK mRNA by glucocorticoids seems to 
result from interaction of an induced factor with an RNA 
element located in the 3' noncoding sequence of the mRNA. 
Studies have been conducted on the PEPCK promoter itself. 
Short (216) identified a 47-bp region of the PEPCK promoter 
determined to be essential for stimulation by dibutyryl cAMP. 
Two glucocorticoid regulatory elements are present within the 
promoter as well as an inhibitory element, which decreases the 
rate of basal gene transcription. Klemm et al. (119) 
indicated that the PEPCK promoter between -490 and +73 
contains sequences responsive to hormonal and tissue-specific 
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factors in nuclei from rat tissues. Roesler et al. (194) 
stressed the importance of cAMP regulatory elements in cAMP 
regulation of transcription, which was first demonstrated in 
studies of the promoter-regulatory region of the gene for rat 
cytosolic PEPCK (GTP). Multiple protein binding domains in 
the promoter-regulatory region of the PEPCK (GTP) gene were 
identified by Roesler et al. (195). They suggested that the 
PEPCK promoter has four binding sites for the cAMP regulatory 
element (CRE)-binding proteins. Short et al. (217) mapped 
hormonal regulatory elements within the PEPCK (GTP) promoter 
region by using a series of 5'-deletions. 
Hod et al. (96) and Weldon et al. (246) concluded that 
the cytosolic and mitochondrial forms of chicken PEPCK are 
encoded by distinct mRNA species. Lamers et al. (130) 
concluded that cAMP induces PEPCK mRNA by increasing the rate 
of gene transcription. Benvenisty and Reshef (27) observed / 
that injection of dibutyryl cAMP on d 19 of gestation in rats 
induces gene expression and DNase I sensitivity, whereas 
longer treatment results in premature hypomethylation of the 
gene. 
Zabala and Garcia-Ruiz (269) observed that the high PEPCK 
activity reported during lactation is the result of increased 
amounts of mRNA for PEPCK, which, in turn, is caused by a 
coordinated response via transcription and post-transcription 
where prolactin seems to play an important role. Imai et al. 
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(102) proposed that the complex glucocorticoid response unit 
(GRU) of the PEPCK gene provided the stringent regulation 
required of this key gluconeogenic enzyme in liver. From 
substrate protection experiments of PEPCK inactivation. 
Cardemi1 et al. (40) concluded that loss of PEPCK activity was 
caused by modification of both thiol and vicinal dithiol 
groups in the substrate binding region. 
Known sequences of PEPCK 
Yoo-Warren et al. (267, 268) isolated and characterized 
the gene coding for cytosolic PEPCK (GTP) from rats by using 
R-loop mapping. The gene is about 6 kb with eight introns. 
Beale et al. (25) deduced the structure of rat hepatic 
cytosolic PEPCK mRNA by sequencing cDNA and genomic DNA and by 
primer extension of the mRNA. The molecule is 2,624 
nucleotides in length and has three RNA polymerase II 
dependent start sites—two on the coding and one on the 
noncoding strand. The protein is 621 amino acids long and has 
a molecular weight of 69,289 daltons. The gene contains 10 
exons and nine introns with a total length of 6 kb. 
Restriction enzyme maps and alignment of exons and introns 
indicate that the gene examined by both groups is identical, 
despite the difference in the number of exons or introns. 
The nucleotide sequence of mRNA encoding the cytosolic 
form of PEPCK (GTP) from chickens was elucidated by Cook et 
al. (50). The message for the enzyme was found to be 2,762 
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bases long and to encode a protein of 622 amino acids with a 
MW of 69,522 daltons. Hod et al. (1984) isolated the gene for 
cytosolic PEPCK (GTP) from chickens. The gene is about 8 kb 
and contains eight exons. Two mRNA species with discrete 5' 
ends were observed. Comparison of sequence with rat cytosolic 
PEPCK indicated a possible control region contained in the 
flanking sequences at the 5' end of the gene. 
Gundelfinger et al. (82) deduced the amino acid sequence 
of PEPCK (GTP) from Drosophila melanoaaster. The predicted 
protein consists of 647 amino acid residues and has a 
calculated MW of 71,129 daltons. Stucka et al. (227) deduced 
the nucleotide sequence of the PEPCK gene from Saccharomvces 
cerevisiae. There were no significant homologies between the 
yeast gene sequence and sequences for the corresponding enzyme 
from rat or chicken liver. 
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SECTION I: CHANGES IN EXPRESSION OF PHOSPHOENOLPYRUVATE 
CARBOXYKINASE GENE DURING DEVELOPMENT OF BOVINE 
LACTATION KETOSIS 
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ABSTRACT 
Expression of the gene for phosphoenolpyruvate 
carboxykinase, a key regulatory enzyme of gluconeogenesis, was 
studied in bovine liver tissue. Twenty Holstein cows were 
assigned randomly to four equal groups. Controls were (a) 
normal weight and (b) obese. Feed restriction and the 
ketogenic precursor, 1,3-butanediol, were used after 14d 
postpartum to attempt to induce ketosis in the two treatment 
groups, (i.e.) normal weight ketotic and obese ketotic. Liver 
biopsies were obtained at several times during the development 
and recovery stages of ketosis. Both control and treated cows 
showed a progressive increase in relative concentrations of 
phosphoenolpyruvate carboxykinase mRNA from 5 through 35 days 
postpartum. Then, a significant decrease in relative 
concentrations of phosphoenolpyruvate carboxykinase mRNA 
occurred in ketotic (P<0.05) cows around day 42 postpartum, 
which is the time when clinical symptoms of ketosis became 
evident. A corresponding decrease also occurred in relative 
phosphoenolpyruvate carboxykinase protein concentrations 
around this time in ketotic cows (P<0.01). The control cows 
did not show as dramatic a decrease in relative concentrations 
of phosphoenolpyruvate carboxykinase mRNA and protein. During 
recovery from ketosis from 49 to 63 days postpartum, the 
relative phosphoenolpyruvate carboxykinase mRNA and protein 
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concentrations decreased further, except for the ketotic cows 
that were obese. Over the entire experimental period, 
relative differences in concentration of bovine liver 
phosphoenolpyruvate carboxykinase protein were correlated 
positively (r = 0.44) with mRNA concentrations for 
phosphoenolpyruvate carboxykinase. A negative correlation 
(P>0.05) of triacylglycerol to glycogen ratio in liver with 
relative phosphoenolpyruvate carboxykinase mRNA concentrations 
(-0.20) and PEPCK protein concentrations (-0.18) also was 
obtained. Because earlier research demonstrated that a high 
triacylglycerol to glycerol ratio (>2 on a weight basis) was 
correlated positively with incidence of fatty liver and 
ketosis, these results suggest a probable role for 
phosphoenolpyruvate carboxykinase gene expression in 
development of bovine lactation ketosis. 
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INTRODUCTION 
Lactation ketosis constitutes a major economic loss for 
U. S. dairy farmers. The costs of clinical and subclinical 
ketosis in the U.S. were estimated to be $150,000,000 even a 
decade ago (23) . Lactation exerts great nutrient stress on 
dairy cows, and thus early lactation is a time during which 
cows are highly vulnerable to developing subclinical or 
clinical ketosis. 
Ruminants, unlike most other mammals, depend upon 
gluconeogenesis for much of their glucose supply (40). During 
lactation, when the demand for milk production increases the 
needs for glucose, the rate of gluconeogenesis increases. 
This increase, mediated by glucagon, is stimulated by greater 
activity of key gluconeogenic enzymes such as 
phosphoenoIpyruvate carboxykinase (PEPCK) (5). As a result of 
greater gluconeogenic activity, the supply of oxaloacetate may 
limit activity of the citric acid cycle. The body then 
reverts to increased /3-oxidation of fatty acids to provide 
acetyl CoA for energy. Accumulation of acetyl CoA leads to 
the formation of ketone bodies because of low concentrations 
of oxaloacetate and the high ratio of NADH to NAD"^ in 
mitochondria. Increased concentrations of ketone bodies 
(acetone, acetoacetate, and j8-hydroxybutyrate) in blood, in 
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turn, leads to bovine lactation ketosis. 
Although extensive studies of liver metabolism during 
ketosis are not available, it is agreed generally that the 
need for glucose exceeds the supply. Probably a decrease in 
hepatic gluconeogenesis during ketosis results from a decrease 
in available substrates (3), rather than decreases in 
activities of key gluconeogenic enzymes in liver (5, 6). 
Recently, however, it was observed (26) that, when liver 
slices were incubated in vitro with saturating amounts of 
gluconeogenic substrates such as alanine, aspartate, 
glutamate, lactate, and propionate, the gluconeogenic capacity 
of the liver seemed to decrease during ketosis (23) . This 
decrease occurred when concentrations of triacylglycerols were 
greater in livers of ketotic cows. These studies (26) were in 
direct contrast to data (24) that showed increases in 
gluconeogenic capacity of the liver during an induced 
ketonemia in steers. The relationship of this apparent 
decrease in hepatic gluconeogenic capacity to the development 
of ketosis remains undefined. 
The current project was designed to study the genetic 
expression of PEPCK during development of bovine lactation 
ketosis. Expression of the gene for PEPCK was evaluated by 
measuring the relative differences in concentration of the 
mRNA for PEPCK and of the PEPCK protein in liver from control 
cows and cows that were prone toward fatty liver and ketosis. 
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MATERIALS AND METHODS 
Design of experiment 
Twenty multiparous Holstein cows housed at the Iowa State 
University dairy farm were fed a total mixed ration of 40% 
grain and 60% forage for ad libitum intake for the first 14 
days postpartum. Cows were assigned into four groups of five 
cows each at the end of the previous lactation. Ten cows were 
fed according to NRC guidelines during dry period (normal 
cows), and 10 cows were made obese by overfeeding them up to 
115% during the preceding dry period (obese cows). A group of 
five normal cows and a group of five obese cows were managed 
under a protocol designed to induce ketosis. The protocol, 
developed in our laboratory (38) and referred to as FRBD, 
involves feed restriction (PR) to 80% of ad libitum intake and 
adding a ketone body precursor (1,3-butanediol, BD) 
incrementally to the diet until BD intake was about 7% of dry 
matter intake. Thus, the four groups were: normal weight 
control cows (NC), normal weight cows subjected to the FRBD 
protocol (NFRBD), obese control cows (OC), and obese cows 
subjected to the FRBD protocol (OFRBD). Control groups (NC 
and OC) were fed for ad libitum intake throughout the 
postpartal period, whereas the other two groups (NFRBD and 
OFRBD) were subjected to the FRBD protocol after d 14 
postpartum. When signs of subclinical or clinical ketosis in 
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any FRBD cow was observed (about 42 d postpartum), she then 
was returned to ad libitum intake and BD was removed from the 
diet. 
Biopsies of liver 
Liver biopsies and blood samples were collected at 
approximately 10 d prepartum (-10) and at 5, 14, 21, 28, 35, 
42, 49, and 63 d postpartum. Liver biopsy samples were frozen 
in liquid nitrogen immediately after biopsy and were later 
transferred to a -80"C freezer for subsequent determination of 
mRNA, protein, glycogen, and triacylglycerol content. Table 1 
explains the relationship between sampling times and the 
different stages of the experiment. Although these stages 
apply to FRBD cows, the same sampling schedule was used for 
control cows. 
Biopsies (19) were collected under local anesthetic. 
About 1 g of liver was taken through a 20-mm incision in the 
skin at the 11th intercostal space. After removal of liver, 
the incision was closed surgically and sprinkled with 
antibiotic sulpha powder (Precise suture staples and Furacin 
powder were from 3M Company, Minneapolis, MN). Liver sampling 
did not cause any major adverse reactions in cows such as 
going off-feed or a major decrease in milk production for the 
subsequent milking. 
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Table 1. Sampling schedule for control and FRBD cows 
Day of sampling relative 
to parturition* 
-10 
+5 
+14 
+21 
+28 
+35 
+42 
+49 
+63 
Stage of experiment 
Pre-induction, Stage 1 
Pre-induction, Stage 2 
Induction, Stage 1 
Induction, Stage 2 
Induction, Stage 3 
Induction, Stage 4 
Ketosis 
Recovery, Stage 1 
Recovery, Stage 2 
"Day of parturition is day 0. 
RNA isolation 
Isolation of total RNA from frozen liver samples was 
performed by the method of Chomczynski and Sacchi (12). RNA 
then was resolved electrophoretica1ly on a 1% agarose gel 
(Seakem GTG Agarose from FMC Bioproducts, Rockland, ME). The 
apparatus used was a Model H5 Horizontal Gel Electrophoresis 
Apparatus and a Model 250 Electrophoresis Power Supply (BRL 
Life Technologies, Inc., Gaithersburg, MD). RNA was resolved 
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at 150 volts for 1 h and photographed by using a UV 
Transilluminator (UVP Inc., San Gabriel, CA). Once good 
quality RNA was ascertained (nondegraded IBS and 28S bands 
were visible), the optical density of total RNA was determined 
on a spectrophotometer (Model Gilford 2600, Gilford Instrument 
Labs Inc., Oberlin, OH). A Bio-Dot SF Assembly slot-blot 
apparatus (Bio-Rad Laboratories, Richmond, CA) then was used 
to transfer RNA to a nitrocellulose membrane (S&S pure 
nitrocellulose, 0.45 /xm pore size, Schleicher and Schuell, 
Keene, NH). The membrane containing RNA was baked for 2 h at 
80'C in a vacuum oven for RNA fixation. The experiment was 
repeated in duplicate for each sample. 
Probe tareparation and slot-blot hvbridizatlon 
About 40 ng of PEPCK cDNA from rat liver cytosol (plasmid 
pPCKlO, kindly supplied by Dr. R. W. Hanson of Case Western 
Reserve University, Cleveland, OH) was used as the probe. The 
construction of this probe was such that a 2.6 kb fragment of 
the PEPCK gene from rat liver was ligated into the plasmid 
vector pBR322 by using the restriction enzyme Pst 1 (37). The 
recombinant DNA was amplified by infection of E. coli Tgfa 
cells grown in LB-Tetracycline medium. Because of an internal 
Pst 1 site in the gene, digestion with Pst 1 cuts the 
recombinant DNA into three pieces—the plasmid vector and a 
1.6 kb large fragment and a 1.0 kb small fragment of the PEPCK 
85 
genè. The 1.6 kb large fragment of the PEPCK gene was used 
for all hybridizations. Labelling of the probe was done by 
using the Random Primer DNA Labelling Kit from Boehringer 
Mannheim Corporation Biochemical Products (Indianapolis, IN) . 
Radioactive dCTP (a-^P dCTP, specific activity of 3000 Ci per 
mmol, from NEN Research Products, Du Pont Company, 
Biotechnology Systems, Wilmington, DE) was used for labeling 
the probe. After incubation of the probe with dTTP, dATP, 
dGTP, radioactive dCTP, and Klenow enzyme at 37'C for 1 h 
(31), DNA synthesis was stopped by adding EDTA. The probe was 
purified from unincorporated a-^^P dCTP by using Select-D (G-
50) columns from 5'-3', Inc. (West Chester, PA). The 
radioactivity incorporated into product was quantified by 
using a scintillation counter, and the efficiency of 
purification of product was resolved by thin-layer 
chromatography. 
Total RNA samples (100, 50, 25, 12.5, 6.25, and 3.125 nq) 
were denatured on a formaldehyde-agarose gel and assayed by 
Northern blot analysis by using slot-blot hybridization (32). 
Both prehybridization and hybridization of membranes 
containing RNA were performed according to the procedures of 
Sambrook et al. (32). Individual membranes were sealed in 
bags with prehybridization fluid (12) and shaken at 42'C for 4 
h. After prehybridization, hybridization fluid (12) was added 
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to an individual membrane and it was shaken again overnight at 
42*C. The resulting hybridized membrane (blot) then was 
washed successively at room temperature two times each for 15 
minutes in IX SSC and 0.5% SDS (32) and then in 0.25X SSC and 
0.5% SDS (SSC and SDS refer to a 3 M sodium chloride, 0.3 M 
sodium citrate solution, and sodium dodecyl sulfate solution, 
respectively). The blot then was sealed in a bag and exposed 
to fresh X-ray film (Kodak Color Labs, Inc., at -80"C in the 
presence of Du Pont Cronex (Lightning Plus) intensifying 
screens (Cassling Diagnostic Imaging, Omaha, NE) for varying 
periods of time until the desired degree of exposure was 
achieved. Exposure to intensifying screens was necessary 
because, as indicated by Swanstrom and Shank (35), X-ray 
intensifying screens greatly enhance detection of ^ ^P by 
autoradiography in the case of both Northern and Southern 
analyses. The radioactive probe was bound to PEPCK mRNA 
present on the blots with varying intensity depending upon the 
relative concentrations of PEPCK mRNA present. After 
resolution of the PEPCK mRNA, the blots were reprobed with 
cDNA for jS-actin, an internal standard, to test for variation 
in loading the samples. 
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Protein extraction 
Cytosolic proteins were extracted from liver tissue by 
the method of Sambrook et al. (32). In brief, the method 
involved homogenizing tissue with sucrose-HEPES buffer, 
filtering through cheesecloth, and centrifuging at 9,000 x g 
for 15 min at 4*C. The concentration of total protein in the 
extracts was determined by using the Bradford assay (10). 
Concentrations were calculated on the basis of bovine serum 
albumin as standard. 
Western analysis of proteins 
Western analyses of cytosolic proteins in bovine liver 
were conducted according to the methods of Ausubel et al. (2). 
The proteins were separated on 12.5% SDS-polyacrylamide gels 
and transferred to a nitrocellulose membrane by using the 
Western transfer apparatus (Mighty Small II SE 250 
electrophoresis minigel apparatus and Model TE 22 mini 
transfer apparatus, Hoefer Scientific Instruments, San 
Francisco, CA). After blocking the binding sites with bovine 
serum albumin, the membrane was incubated at room temperature 
with goat anti-rat PEPCK antibody (kindly supplied by Dr. D. 
K. Granner, Vanderbilt University, Nashville, TN). The 
membrane was washed and incubated with secondary antibody, 
"^I-protein A (specific activity 87.4 nCi per iig, NEN Research 
88 
Products, Du Pont Company, Biotechnology Systems, Wilmington, 
DE). After washing three times in rinse buffer (10 mM Tris-
HCl at pH 8.0, 1 mM EDTA, 0.1% Triton X-100, and 1 M NaCl) at 
30 min each, the membrane was dried in air and exposed to X-
ray film with intensifying 
screens. 
Quantitation from scots on autoradioarams 
To measure relative differences in PEPCK mRNA 
concentrations by hybridization, it was necessary to establish 
appropriate conditions for such an assay. Both the mRNA and 
protein spots on autoradiograms were quantitated (9, 36) by 
determining the total optical density through the center of a 
spot and area of spot for each liver sample by using a 
scanning densitometer (LKB Bromma 2202 Ultrascan Laser 
Densitometer, and LKB Bromma 2220 Recording Integrator, LKB-
Produkter AB Electrophoresis Products, Bromma, Sweden). The 
autoradiogram image densities were proportional to the amount 
of RNA present on the membranes when 5-100 nq were probed with 
^^P-pPCKlO or to the amount of protein when 30-50 fig were 
probed with '%^-protein A and goat anti-rat PEPCK antibody. 
The ^ ^P-pPCKlO probe did not bind to RNAs isolated from tissues 
that did not make PEPCK or to tRNA or rRNA, and the protein 
antibody did not bind to tissues that did not make PEPCK 
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protein (data not shown). Moreover, the addition of up to 200 
/ig of RNA per spot or 100 /ig of protein per lane had no effect 
on the quantity of probe hybridized (data not shown). These 
results indicate that the quantitation method can be used to 
determine relative concentrations of specific mRNAs and 
proteins. 
Blots containing RNA then were stripped and reprobed with 
cDNA for j8-actin (14) because actin is present in constant 
amounts in the liver at all times. Similar measurements of 
hybridization of ^^P-j8-actin cDNA (labeled in a similar manner 
to pPCKlO) to the blots were made by densitometry. The RNA 
values were adjusted for experimental error on the basis of 
the actin measurements. 
Relative differences in concentrations of PEPCK mRNA and 
PEPCK protein were expressed in terms of arbitrary units (8, 
9) from the concentration at d -10 (d 10 prepartum), which was 
arbitrarily set as 1.0. This normalization also had the 
advantage of adjusting for differences in the initial status 
of cows. The results of hybridization depend upon several 
factors, including the sensitivity setting of the 
densitometer, the amount of RNA or protein per spot, the 
concentration and specific activity of the probe, and the time 
of exposure of the autoradiogram. We have optimized each of 
these factors to insure that the integrated image density is 
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directly proportional to the amount of PEPCK mRNA present. 
The blots thus provide a measure of the relative amounts of 
PEPCK mRNA and PEPCK protein in samples assayed together. 
Determination of alvcoaen and triacvlalvcerol content of liver 
Glycogen concentrations of liver were determined by the 
methods of Keppler and Decker (21). Frozen liver samples were 
thawed, refrozen in liquid nitrogen, and pulverized by 
grinding with a mortar and pestle. Approximately half of each 
sample was weighed and homogenized in 5 vol of 10% perchloric 
acid. The resulting suspension was used for determination of 
glycogen concentration. 
The other half of each sample was weighed and placed in 
10 ml of 2:1 chloroform;methanol for lipid extraction. 
Concentrations of triacylglycerol were determined by using a 
modification of a commercial kit (triglyceride GPO Trinder 
kit, Sigma Chemical Co., St. Louis, MO). Samples were allowed 
to shake for at least 2 h; then, 4 ml of water were added, and 
samples were vortexed vigorously and centrifuged. After 
centrifugation, the chloroform layer was separated. The lipid 
extract then was dissolved in 95% ethanol and assayed for 
triacylglycerol concentration. 
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Statistical analyses 
Data were analyzed by using GLM (25) and orthogonal 
comparisons of GLM (31) to compare stage differences of the 
experiment within treatments. A split-plot design was used 
with treatments as the main effect and with cows-within-
treatment as error A and with stage and treatment by stage 
interaction as subplots. Because of missing values at some 
stages, LSMEANS were calculated and used for statistical 
analysis (25). 
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RESULTS 
A protocol to induce fatty liver usually followed by 
lactation ketosis in early postparturient cows has been 
developed in our laboratory (38) . When the FRBD protocol was 
initiated at d 15 postpartum, the liver lipid increased until 
10 to 12% of liver wet weight was triacylglycerols. Cows 
gradually developed signs of ketosis, including increased 
ketone body production, anorexia, and decreased milk 
production; at an average of about 42 d postpartum, they 
became subclinically or clinically ketotic. Of all the FRBD-
treated cows studied, only three became clinically ketotic 
(one cow from the NFRBD group and two cows from the OFRBD 
group), and these were treated with intravenous infusions of 
glucose (38) . Recovery was rapid, and the cows were retained 
on the experiment. After obtaining a liver biopsy sample at 
ketosis, no further samples were obtained from these cows 
until recovery from ketosis, and statistical analyses were 
conducted accordingly. 
PEPCK mRNA concentrations 
Bovine liver RNA from the four groups of cows was probed 
with the cDNA probe for cytosolic PEPCK from rat liver, ^^P-
pPCKlO (39), by using slot-blot hybridizations (8). For the 
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sake of evaluating the relationship of expression of the gene 
for PEPCK to development of fatty liver and ketosis, the 
experimental period was divided into four stages: pre-
induction (5-14 d postpartum), induction (15-35 d postpartum), 
ketosis (42 d postpartum), and recovery from ketosis (49-63 d 
postpartum). The effects of treatment and stage of ketosis on 
the relative changes in concentration of mRNA for PEPCK are 
shown in Figure 1. The linear, quadratic, and cubic effects 
of time upon the relative changes in concentration of PEPCK 
mRNA in the cows were significant (P<0.05). Relative 
concentrations of PEPCK mRNA increased progressively in all 
four groups during early lactation, peaking at about d 35 
postpartum, and decreasing from then on until d 63 postpartum. 
The only exception was the OFRBD group, which showed an 
increase in relative concentrations of PEPCK mRNA during the 
period of recovery from ketosis. The relative concentrations 
of PEPCK mRNA in control cows did not exhibit as dramatic a 
decrease at ketosis (d 42) as did the FRBD cows (P<0.05). 
The variation among body condition and diet observed 
among the cows studied at parturition prompted normalization 
of the data (8, 9) to adjust for differences of initial status 
of cows. The relative changes in concentration of PEPCK mRNA 
were determined after correction for the initial value (10 d 
prepartum). Then, average relative concentrations of mRNA for 
PEPCK were calculated for each of the four groups of cows. 
Figure 1. Relative changes in PEPCK mRNA concentrations in 
liver during early lactation. Differences 
are expressed as relative changes from values at d 
-10, which have been normalized to 1.0. Time refers 
to days before or after parturition on d 0. The 
average standard error of the mean for NC (•) group is 
0.05, for NFRBD (A) is 0.06, for OC (O) is 0.04, and 
for OFRBD (*) is 0.03. 
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Adjusted data are presented in Table 2. Significances are 
discussed with respect to the interaction of the effects of 
treatment, time, and diet on the cows. The average relative 
differences in concentration of mRNA for PEPCK in both groups 
of control cows during the entire period of early lactation 
was about 5% greater than that in both groups of FRBD-treated 
cows. The difference, however, was not statistically 
significant (P>0.05). The relative changes in PEPCK mRNA 
values during the entire period of early lactation for both 
the normal weight cows were not different (P>0.05) from those 
for both groups of obese cows (Table 2). 
The relative differences in concentrations of PEPCK mRNA 
during pre-induction stage of the four groups were not 
different (P>0.05). During the induction period and when FRBD 
had been initiated, the relative differences in concentrations 
of PEPCK mRNA were slightly different for the four groups 
(P<0.05). Relative expression of the PEPCK gene increased 
slowly in all four groups and peaked at d 35 postpartum 
(Figure 1). The differences between values for normal weight 
and obese cows were slightly different (P<0.05). At ketosis, 
relative differences in concentration of PEPCK mRNA in livers 
of FRBD cows were less than those in control cows (P<0.05). 
During recovery from ketosis, relative differences in PEPCK 
mRNA concentrations in all groups except OFRBD decreased 
(P>0.05). The decrease in relative concentrations of 
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Table 2. Relative concentrations of PEPCK mRNA in control and 
FRBD cows during early lactation 
Stage of experiment*" 
Treatment' Pre-induction Induction Ketosis Recovery 
•Relative changes® 
NC (5) 1. 05±0. 02 1.31±0.05 1. 37+0. 05"'l.08±0.06 
NFRBD (5) 1. 11±0. 05 1.42+0.07dl. 13+0. 06 1.04±0.01 
OC (3) 1. 10±0. 08 1.30+0.06 1. 35+0. 04 1.16±0.05 
OFRBD (5) 1. 22±0. lO' 1.23±0.06''l. 11+0. 03' 1.15±0.01 
'NC refers to normal weight controls, NFRBD to normal weight 
FRBD-treated, OC to obese controls, and OFRBD to obese FRBD 
-treated. Numbers in parentheses indicate number of cows in 
each group. Samples were not available for two OC cows. 
•"Pre-induction includes d 5 and 14, induction includes d 21, 
28, and 35, ketosis is d 42, and recovery includes d 49 and 
63 postpartum. 
"All values are means ± SE and have been corrected by 
normalization for differences at day -10. Equal amounts of 
RNA were applied to each spot. Changes in relative 
concentrations of PEPCK mRNA are expressed as relative 
changes from d -10, which are considered to be 1.0. 
("Treatment means with superscripts within a column are 
significant at P<0.05. 
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PEPCK mRNA at d 49 was sharper (P<0.05) compared to that at d 
63 for the other three groups. 
To verify that data obtained for PEPCK mRNA were not the 
result of any experimental discrepancies, the blot was 
stripped and reprobed with cDNA for jS-actin. The 
concentration of j8-actin mRNA was relatively constant (14) 
during all the four stages of experiment assayed (data not 
shown). Hence, the relative differences in concentrations of 
PEPCK mRNA were the result of differences in concentration 
within the liver cells rather than differences in amount of 
sample placed on blot. 
PEPCK protein concentrations 
Western transfer of proteins extracted from bovine liver 
was conducted successfully (2). The primary antibody used was 
goat anti rat PEPCK, and the secondary antibody used was '"l-
protein A. For the sake of evaluating the relationship of 
expression of the gene for PEPCK to development of fatty liver 
and ketosis, the experimental period was divided into four 
stages: pre-induction (5-14 d postpartum), induction (15-35 d 
postpartum), ketosis (42 d postpartum), and recovery from 
ketosis (49-63 d postpartum). The effects of treatment and 
lactation on the relative differences in concentration of 
PEPCK protein are shown in Figure 2. The linear, quadratic. 
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and cubic effects of time upon the relative changes in 
concentration of PEPCK protein in the cows were significant 
(P<0.05). Relative concentrations of PEPCK protein increased 
progressively in all four treatment groups during early 
lactation, peaking at about d 35 postpartum, and decreasing 
from then on until d 63 postpartum. The only exception was 
the OFRBD group, which showed an increase in relative 
concentrations of PEPCK protein during the period of recovery 
from ketosis. The relative concentrations of PEPCK protein in 
control cows did not exhibit as dramatic a decrease at ketosis 
(d 42) as did the FRBD cows (P<0.01). 
As with PEPCK mRNA, the variation among body condition 
and diet observed among the cows studied at parturition 
prompted normalization of the data (8, 9) to adjust for 
Figure 2. Relative changes in PEPCK protein concentrations 
in liver during early lactation. Differences 
are expressed as relative changes from values at d 
-10, which have been normalized to 1.0. Time refers 
to days before or after parturition on d 0. The 
average standard error of the mean for NC (•) group 
is 0.04, for NFRBD (A) is 0.06, for OC (O) is 0.03, 
and for OFRBD (*) is 0.02. 
Relative changes in PEPCK protein 
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differences of initial status of cows. The relative changes 
in concentration of PEPCK protein were determined after 
correction for the initial value (10 d prepartum). Then, 
average relative concentrations of PEPCK protein were 
calculated for each of the four groups of cows. Adjusted data 
are presented in Table 3. Significances are discussed with 
respect to the interaction of the effects of treatment, time, 
and diet on the cows. The average relative changes in 
concentration of PEPCK protein in both groups of control cows 
during the entire period of early lactation was about 12% 
greater than that in both groups of FRBD-treated cows. 
Average relative changes in PEPCK protein values for both 
normal weight groups during the entire period of early 
lactation were about 6% higher than those for both obese 
groups. The cows to be treated with FRBD exhibited slightly 
different values for PEPCK protein concentrations compared to 
those of controls (P<0.05) during the pre-induction stage. 
The relative differences in concentration of PEPCK protein 
during the pre-induction stage for normal weight cows were 
greater than those for obese cows (P<0.05). These results 
suggest that obese cows may be more susceptible to ketosis 
because of less PEPCK. At induction, the relative differences 
in PEPCK protein concentrations for the FRBD groups were 
different from those of the control groups (P<0.05), whereas 
the normal weight cows had slightly greater relative 
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Table 3. Relative concentrations of PEPCK protein in control 
and FRBD cows during early lactation 
Stage of experiment^ 
Treatment' Pre-induction Induction Ketosis Recovery 
Relative changes® 
NC ( 5 )  1 .  0 9 + 0 .  0 1  1 .  3 1 + 0 .  0 6  1 .  3 5 ± 0 .  04*" 1 . 1 7 ± 0 . 0 6  
NFRBD ( 5 )  1 .  0 5 + 0 .  0 3  1 .  3 5 ± 0 .  05"" 1  .  1 3 ± 0  . 0 5  1 . 0 2 + 0 . 0 5  
O C  ( 3 )  1 .  0 7  +  0 .  0 8  1 .  2 6 ± 0 .  0 4  1 .  2 9 + 0 .  0 3  1 . 1 8 ± 0 . 0 2  
OFRBD ( 5 )  0 .  9 8 ± 0 .  0 4  1 .  1 2 + 0 .  06' 1  .  0 0 ± 0  o
 
to
 
1 . 0 6 ± 0 . 0 4  
"NC refers to normal weight controls, NFRBD to normal weight 
FRBD-treated, OC to obese controls, and OFRBD to obese FRBD 
-treated. Numbers in parentheses indicate number of cows in 
each group. 
•"Pre-induction includes d 5 and 14, induction includes d 21, 
28, and 35, ketosis is d 42, and recovery includes d 49 and 
63 postpartum. 
"All values are means ± SE and have been corrected by 
normalization for differences at day -10. Equal amounts of 
protein were applied to each spot. Changes in relative 
concentrations of PEPCK protein are expressed as fold changes 
from d -10, which is considered to be 1.0. 
•"Treatment means with superscripts within a column are 
significant at P<0.05. 
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concentrations of PEPCK protein when compared with the obese 
cows (P<0.05). At ketosis, the FRBD cows had less relative 
PEPCK protein in livers than did control cows (P<0.01) whereas 
normal weight cows had slightly higher values than did obese 
cows (P<0.05). During recovery from ketosis, the 
concentrations of PEPCK protein decreased further for all 
groups (P>0.05) except for the OFRBD. The decrease in 
relative concentrations of PEPCK protein at d 49 was sharper 
(P<0.05) compared to that at d 63 for the other three groups. 
Triacvlalvcerol to alvcoqen ratio in liver 
The ratio of triacylglycerol to glycogen in liver varied 
in the four groups during early lactation (Table 4), with 
average values for both normal weight groups of cows showing 
almost a 6-fold lower ratio (P<0.05) than those for both obese 
groups of cows. There was a significant increasing effect of 
FRBD treatment on triacylglycerol/glycogen (P<0.05). The data 
in Table 4 were analyzed by covariance for adjusting for 
differences at d -10. The overall ratio of 
triacylglycerol/glycogen in all groups was found to be 2.75 ± 
1.09. 
Correlation coefficients of the triacylglycerol to 
glycogen ratio in liver with relative changes in both PEPCK 
mRNA and protein are presented in Table 4. There was an 
average negative correlation (P>0.05) between the 
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Table 4. Ratio of triacylglycerol (TAG) to glycogen in liver 
from control and FRBD cows and correlations to 
PEPCK 
Correlation coefficients for 
Treatment' TAG/glycogen PEPCK mRNA PEPCK protein*" 
to TAG/glycogen to TAG/glycogen 
NC 0.47 ± 0.16= (12) o
 (O
 
o
 
(4) o 
o
 (12) 
NFRBD 1.23 ± 0.54 (14) -0.17 (10) 0.17 (14) 
OC 3.93 ± 1.14 (13) -0.32 (12) -0.55" (13) 
OFRBD 5.77 ± 4.76 (11) -0.21 (8) -0.23 (11) 
Average 2.75 ± 1.09 
o
 
CM 0
 1 
CO rH O
 1 
'NC refers to normal weight controls, NFRBD to normal weight 
FRBD-treated, OC to obese controls, and OFRBD to obese FRBD 
-treated. Numbers in parentheses indicate number of samples 
used for the analyses. 
^Correlation coefficients were calculated on the basis of 
individual values of triacylglycerol, glycogen, and relative 
differences in PEPCK mRNA or protein for each cow and 
averaged within each of the four treatment groups. 
"All values are means ± standard error after being corrected by 
covariance for differences in initial values. Means were 
obtained by averaging individual triacylglycerol to glycogen 
ratios for each cow in each of the four treatment groups 
during the entire period of early lactation. 
""Treatment means with superscripts within a column are 
significant at P<0.05. 
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triacylglycerol to glycogen ratio and relative PEPCK iiiRNA 
concentrations (-0.20), and between the triacylglycerol to 
glycogen ratio and relative PEPCK protein concentrations (-
0.18), suggesting that both PEPCK mRNA and PEPCK protein 
relatively decreased as the triacylglycerol to glycogen ratio 
increased. 
Correlation of PEPCK mRNA and PEPCK protein 
A correlation analysis was conducted with the data 
obtained. The correlation between relative changes in 
concentrations of PEPCK mRNA and PEPCK protein (r = 0.44) was 
highly significant (P<0.001). A significant correlation would 
be expected because the mRNA for PEPCK is used for translation 
of the PEPCK enzyme. 
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DISCUSSION 
Induction of clinical ketosis by using the FRBD protocol 
confirms previous results from our laboratory (25). Studies 
with fasted cows (3) and with spontaneously ketotic cows (4, 
34) have shown some profiles of blood and liver metabolites 
that are similar to those noted for the onset of subclinical 
or clinical ketosis in the FRBD cows. 
It is possible that relative concentrations of PEPCK mRNA 
can be controlled at transcription, at processing of immature 
mRNA, or at translation (22). Intracellular concentrations of 
mRNA can be changed (1) by three mechanisms: (a) change in 
rates of synthesis, (b) variation in rates of degradation, or 
(c) modification of messenger availability or activity by 
differential storage of mature mRNA in a protein complex 
before initiating protein synthesis or modification of mRNA in 
cytosol. 
Tilghman et al. (37) verified that major changes of PEPCK 
concentrations in tissue were the result of changes in 
synthetic rate, which is under hormonal control. No effect of 
hormones on PEPCK degradation has been detected (16, 37). The 
observation in the present study that PEPCK mRNA and protein 
concentrations change in parallel (r = 0.44) suggests that 
changes in PEPCK activities are regulated at the 
transcriptional rather than at the translational level. These 
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findings are supported by lynedjian et al. (20) who observed 
that, in every case measured, amounts of mRNA for PEPCK and 
rates of PEPCK synthesis changed in parallel and that no 
untranslated pools of PEPCK mRNA were present whose 
translation could be stimulated by cAMP. 
The hypothesis that PEPCK mRNA is regulated primarily at 
the transcriptional level in ketosis is supported further by 
Sasaki et al. (32) and by Bartels et al. (7) who indicated 
that PEPCK activity and PEPCK concentration were regulated 
mainly at the pretranslational level. So, the relative 
decrease in PEPCK mRNA during ketosis must be the result of a 
decreased rate of mRNA synthesis. Some possible explanations 
for this decreased rate of synthesis could be inhibition of 
transcription by some unknown factor, a block in processing of 
heterogenous nuclear RNA to mRNA, a prevention of transport of 
mRNA from nucleus to cytosol, or a degradation of the mRNA 
itself in the cytosol. It is important to note that 
differences between control and FRBD cows occur only when 
signs of ketosis were evident. The observation in the present 
study that the obese FRBD cows had increased relative 
concentrations of PEPCK mRNA during recovery from ketosis 
suggests that this effect of the inhibitors may not be 
permanent or irreversible. 
The hypothesis of a transcriptional inhibitor during 
ketosis is supported by Faliks et al. (15), who observed that 
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decay of PEPCK mRNA upon treatment with insulin or cordycepin 
was the result of a decrease in functional mRNA. They 
suggested that a general system for inactivating mRNA may be 
present in rat liver, which may involve a peptide factor. 
Possibly such a factor also exists in cow liver, which causes 
PEPCK mRNA concentrations to decrease appreciably during 
ketosis. Regulation of this system or factor might be of 
great significance in regulating translatable mRNAs. 
Although highly unlikely, low insulin concentrations, to 
which the PEPCK gene is very sensitive (13), could regulate 
reciprocally the gene at the time of ketosis development. 
Nelson et al. (29) observed that PEPCK synthesis may be 
regulated through template concentrations. Other possible 
reasons for decreased PEPCK concentrations during ketosis may 
be: a decreased oxaloacetate availability because of a low OAA 
to malate ratio in the mitochondria, a shift in the 
intramitochondrial redox potential or NAD+/NADH ratio, or a 
lack of OAA precursors such as propionate. 
The half life of PEPCK mRNA seems to be very short, about 
40 min (17). Therefore, because no known pool of PEPCK mRNA 
seems available, PEPCK mRNA concentration decreases rapidly. 
Although a decrease in gluconeogenic capacity of the liver has 
been detected at diagnosis of ketosis (26), it is not yet 
clear whether ketosis is the result or the cause of impaired 
liver metabolism. Our results suggest that decreased 
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concentrations of PEPCK mRNA around the time when signs of 
clinical ketosis become evident may be the result of a 
decrease in synthesis and that modification of the gene is 
probably transcriptional in nature. 
Cows that are obese at calving are subject to a complex 
of metabolic diseases called the "fat cow syndrome" (27). In 
one high-incidence herd, morbidity was 82% and mortality was 
25% (28). Earlier researchers (11, 30) have found an 
increased ratio (>2 by weight) of triacylglycerol to glycogen 
in livers of ketotic cows and proposed that development of 
fatty liver could lead to ketosis. It is generally agreed 
that triacylglycerol is the major lipid accumulating in cows 
with either postparturient or starvation-induced fatty livers 
or in cows with spontaneous ketosis. The present results 
agree with earlier studies (26, 38), where there was an 
increased triacylglycerol to glycogen ratio in the liver 
during an induced ketosis in dairy cows. Thus, the negative 
correlation of triacylglycerol to glycogen ratio with relative 
changes in concentrations of PEPCK mRNA and PEPCK protein 
obtained in this study strengthens the hypothesis that 
expression of the PEPCK gene may be involved in the 
development of ketosis. 
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SECTION II: AMPLIFICATION OF BOVINE PHOSPHOENOLPYRUVATE 
CARBOXYKINASE cDNA BY USING POLYMERASE CHAIN 
REACTION 
117 
ABSTRACT 
Genomic DNA sequences for the phosphoenolpyruvate 
carboxykinase gene were compared among rat, chicken, 
Saccharomvces cerevisiae. and Drosophila melanoaaster. A 
region of high homology near the 5' end of the gene was 
selected. On the basis of selected sequences, synthetic 
oligonucleotides were constructed for use as primers in 
polymerase chain reactions that used genomic DNA extracted 
from cows and rats as templates. A small, 200-base pair piece 
of genomic DNA was amplified for both species. Sequencing of 
the amplified fragments indicated several regions of homology 
(78%) . In another experiment, the first strand of bovine cDNA 
was generated and used as template in a polymerase chain 
reaction with the same synthetic primers. This experiment 
resulted in amplification of a 960-base pair fragment of 
phosphoenolpyruvate carboxykinase cDNA, the sequence of which 
was very homologous (80%) to that of rat phosphoenolpyruvate 
carboxykinase cDNA. These results demonstrate that the 
polymerase chain reaction method can be used to amplify part 
of the bovine phosphoenolpyruvate carboxykinase cDNA and also 
to generate homologous primers for Northern/Southern 
hybridizations. 
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INTRODUCTION 
In recent years, polymerase chain reaction has been used 
to generate highly efficient hybridization probes for both 
Northern and Southern hybridizations (1). Frohman et al. (6) 
reported successful production of full-length cDNAs from rare 
transcripts by using specific oligonucleotide primers. This 
method was followed by several others (5) for amplification of 
small fragments of genomic DNA, making it possible to amplify 
almost any sequence under consideration. Although nucleotide 
sequences for the PEPCK gene from rat (12), chicken (4), 
Saccharomvces cerevisiae (10), and Drosophila melanoaaster (7) 
have been determined, no reports of sequences of the bovine 
PEPCK gene have been made to date. In view of the importance 
of PEPCK gene regulation in cows, it was thought appropriate 
to amplify part of the bovine PEPCK gene by using PGR. In the 
current report, primers were synthetically constructed on the 
basis of a comparison of homologous sequences between known 
PEPCK genes. These primers then were used to amplify PEPCK 
cDNA from both total DNA and cDNA from bovine liver. 
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MATERIALS AND METHODS 
Construction of synthetic primers 
Genomic DNA sequences for the PEPCK gene were compared 
among rat (12), chicken (4), Saccharomvces cerevisiae (10), 
and Drosophila melanoaaster (7). A 960-bp stretch near the 
5'end of the PEPCK gene, which seemed to be homologous among 
these species, was selected. From this stretch, two specific 
25 bp regions, one near the 5' and the other near the 3' end, 
were chosen as nucleotide sequences for synthetic primers. 
These oligonucleotide primers were synthesized in a 391 PCR 
Mate DNA synthesizer (Applied Biosystems Inc., Foster City, 
CA) at the Nucleic Acid Facility of Iowa State University, 
Ames, lA. AmpliTaq DNA polymerase was purchased from 
Perkin-Elmer Cetus (Norwalk, CT). PCR was performed in a 
Hybaid Thermal Cycler (Midwest Scientific, Valley Park, MO). 
The synthetic primers used were 
Primer 1 (5' GCGCGAGCTCGAAAGCAAGACGGTC 3') and 
Primer 2 (5' CGCGCTGCAGGCTGGCAGGGGTGCA 3'). 
Conditions for PCR 
The conditions used were a modification of the conditions 
described in the GeneAmp II DNA Amplification (PCR) Reagent 
Kit (Perkin-Elmer Cetus, Norwalk, CT) ). A 50-jLtl total volume 
of reaction mixture contained the following; 10 mM Tris-HCl, 
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pH 8.3, 2.5 mM MgClj, 50 mM KCl, 0.01% gelatin, 200 jtiM of each 
dNTP, 0.85 mm of each PGR primer, and 1.25 U of the AmpliTaq. 
Variable quantities of genomic DNA ( 500, 250, and 125 ng) 
from rat liver, cow liver, and bovine whole blood were used 
for the reactions. Double-stranded rat liver PEPCK cDNA 
(pPCKlO, 1 jug) was assayed as a control. The PGR cycles were 
carried out as follows; 10 cycles of 1 min at 94'G, 1 min at 
45'G, and 2 min at 72*G; 35 cycles of 1 min at 94'C, 1 min at 
60*G, and 2 min at 72*G; and 1 cycle of 5 min at 72'G. 
Amplification of bovine cDNA 
In the second experiment, total bovine RNA was isolated 
(3) and purified on an oligo dT column (9). The first strand 
of bovine cDNA then was synthesized by using a c-Glone II cDNA 
synthesis kit (Glontech Laboratories, Inc., Palo Alto, GA). 
Variable quantities of this cDNA (680, 340, 170, and 68 ng) 
then were used in the PGR reaction. The reaction mix and 
primers were as described already. Rat PEPGK cDNA (pPGKlO, 
500 ng) was used as a control in the reaction. The PGR 
products were resolved on a 1% agarose gel to check for 
amplification, and then 40 /il of the products were used for 
electroelution (9). The probe, pPGKlO, was kindly supplied by 
Dr. R. W. Hanson of Case Western Reserve University, 
Cleveland, OH. 
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Sequencing 
Sequencing of the PGR products was performed in a 373A 
DNA (11) Sequencing System (Applied Biosystems, Inc., Foster 
City, CA), at the Nucleic Acid Facility, Iowa State 
University, Ames, lA. 
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RESULTS AND DISCUSSION 
A comparison was made of genomic DNA sequences for the 
PEPCK gene among rat (12), chicken (4), Saccharomvces 
cerevisiae flOÏ, and Drosophila melanoqaster (7). Based on a 
very homologous region near the 5' end of these sequences, 
common synthetic primers were constructed for PGR. The 
synthetic primers were able to amplify a 200-bp segment of 
PEPCK from genomic DNA from both the cow and rat. The 200-bp 
DNA fragments amplified, using genomic rat and cow DNA as the 
template and the synthetic primers to prime the reaction, were 
found to have identical sequences (data not shown). These 
amplified fragments may represent a region of great homology 
between species in the PEPCK gene. Figure 1 illustrates an 
electrophoretic analysis of the products of the PGR reaction. 
In the double-stranded rat cDNA used as control, a 960-bp 
region was amplified, the sequence of which was similar to 
that deduced for PEPCK by Cook et al. (4). This large 
fragment also was amplified by PGR by using bovine cDNA, and 
subsequently the product was sequenced. The negative control 
contained only water, and absence of any reaction in this lane 
showed that the reaction was correct. 
In a second experiment, bovine mRNA was isolated and 
the first strand of cDNA was synthesized. The same synthetic 
primers constructed previously then were used to prime a PGR 
Figure 1: Electrophoretic analysis of amplification of PEPCK 
cDNA from cow and rat liver by PGR. Lane 1: X 
standard cut with Hind III and EcoRl. Lanes 2-4; 500, 
250 and 125 ng of cow liver genomic DNA, Lane 5; 1 jug 
of rat liver PEPCK cDNA (control), Lane 6: 250 ng of 
rat liver genomic DNA, Lanes 7-9; 500, 250 and 125 ng 
of cow blood DNA, Lane 10; kit control, Lane 11; water 
(negative control). 
960 bp 
200 bp 
1 2  3 4 5 6 7 8 9  1 0 1 1  
Figure 2: Electrophoretic analysis of amplification of bovine 
cDNA by PGR. Lane 1: X standard cut with Hind III and 
EcoRl, Lane 2: 500 ng of rat PEPCK cDNA (control), 
Lanes 3-6: 680, 340, 170 and 68 ng of bovine cDNA, 
Lane 7; water (negative control). 
960 bp 
1 2  3  4  5  6  7  
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reaction with the bovine cDNA. Figure 2 illustrates an 
electrophoretic analysis of products from the PGR reaction. A 
960-bp fragment of bovine cDNA was amplified, and it exhibited 
appreciable homology (80%) when sequenced and compared with 
rat PEPCK cDNA, which was used as a control (Figue 3). 
Specific regions of homology were seen throughout the 
amplified sequence, but there seemed to be greater homology 
nearer the 5' end of the amplified segment compared with the 
3' end. The bovine probe generated from the cDNA then was 
used successfully in Northern hybridizations of rat and bovine 
liver RNA (results not shown). 
Upon sequencing both bovine and rat cDNA, a frameshift 
occurs in the sequences between the two cDNAs between 
nucleotide 109 and 258 (Figure 3). Other than this frameshift 
and other minor base pair differences, the sequences seem to 
be very similar (80% homology). The frameshift was confirmed 
to be genuine by repeating the sequencing several times. The 
reliability of the method used for sequencing has been 
demonstrated earlier (11). This frameshift may be the basis 
of a difference between the rat and the cow sequences and may 
explain the difficulty in performing Northern hybridizations 
with the large heterologous probe previously employed (pPCKlO 
- (12), used in Section I of this dissertation). 
The pPCKlO probe was 2.6 kb long and was cloned into 
pBR322 in such a manner that digestion with Pst I not only 
Figure 3: Amplified sequences of the first strand of cDNA from 
cow and rat cytosolic PEPCK cDNA obtained from PGR of 
the first strand of cDNA. The cow sequences are on 
the top line, and the differences in rat sequence are 
shown on the bottom line. Base 109 and 258 are 
indicated by underlining, because this is the region 
where the frameshift occurs. N represents any of the 
four bases A, G, C, or T. 
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5' 
GAAAGCAAGACGGTCATCATCACCCAAGAGCAGAGAGACACCGTGCCCAT cow 
TT N rat 
CCCCAAAAGTGGGCAGAGACAGCTGGGCCGCTGGATGTCAGAAGAGGACT 
C 
TCGAGAAAGCATTCAACGCCAGGTTCCCGGGGTGCATGAAAGGCCGCACC 
C GCAT CA CGC AG T C G TGCATGA G C GCAC 
ATGTATGTCATCCCATTCAGCATGGGGCCGCTGGGCTCACCTCTGGCCAA 
TGTATGTCATC AT CAGCATG GCCGCTG CTCAC TCTG C A G 
GATTGGTATTGAGCTGACAGACTCGCCCTATGTGGTGGCCAGCATGCGGA 
AT G TAT GAGCTGACAGACTCGC TATGTG TG C AGCATGCG AT 
TCATGACAACGGATGGGGACCTCTGTGTTGGAGGCCCTGGGCGATGGGGA 
CATGACAC 
GTTTATCAAGTGCCTCCACTCCGTGGGGTGCCCTCTCCCCTTAAAAAAGC 
CGT GTG CTCT C T AA 
CTTTGGTCAACAACTGGGCCTGCAACCCCGAGCTGACCCTGATTGCTCAC 
GCC TTGGTCA CAACT GG C TGCAA CCC GAGT TGACCCTGATTG 
CTCCCGGACCGCAGAGAGATCATCTCCTTCGGAAGCGGGATTACGGTGGG 
A CTC CGGACCGCAGG GGAGA CATCTCCTTCCGGA GC GATA 
AACTCAACTGCTTGGTAAAGAAATGCTTTTGGCGCTGTTGGATCCGCAGC 
CGG GG GAA CAC T T GGGAAG AAAATGCT TGGC C G G T 
AAGGATTGATTAAGGGAGGGAAGGGGTACGCTTTTCGGCTCACAATTCTT 
TC CCACA GGCTGT TTA CA G C CCT C G CACGA 
TTACCCTCGCCAATTCTTAACCCCCCCTCCCAACCACGAAATCTCCCAGT 
A T C T TCC GGGGAAT AC T C C CCTT TAAATAC 
AAGAAAGCCCTCCCCCACTTCCCCCCTTCGGCATAACCCCCCCTGCTCTT 
CTC TT C T AAAG CC C C TG T T 
TTGTTACCCCCCCCCCCCCCCCTCTAAAATCTCACTTCTCTTTGCTCTAC 
A A C AA T CT C C CC C CC C CT G 
CAAAATTCCCCTTTCTACTTTTGCTCCCCCCCTACCTTTCTGGGCAACCC 
C C  A T T  T A  A A  T  T T  T  
CTCTCCTCTCTTTTTTGGGTCCTCCCCCCCCCCTACCTTTATTCTCCCCC 
G  T C  C  C  C A  T G G T C  
TCGCCCCTTCCCCACCCACCAGACAAGTGATGGGGGTGTTTACTGGGAAG 
C A 
GCATCGATGAGCCCCTGGCCCCAGGAGTCACCATCACTTCCTGGAAGAAC 
AA GAGTGG GA ACA GATG AC GTGCG C A CAACTCGCG 
ATTCTGCACC 
CC GCCAG 
3' 
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cuts it out of the vector but also splits it into a large and 
small fragment of 1.6 kb and 1.0 kb, respectively. Part of 
the problem with trying to hybridize this probe to cow mRNA 
might have been its size and the fact that the secondary 
structure of the RNA caused it to fold upon itself and 
decrease the regions accessible to hybridization. By using 
smaller probes that have sequences known to be more homologous 
among species therefore would have been more logical. 
This simple method of generating homologous probes can be 
used for amplifying different DNA fragments (2). Detection by 
ethidium bromide staining of agarose gels or by more sensitive 
methods such as dot-blots or Southern hybridizations also may 
be used (9). Further reamplification of PGR products can be 
performed if the initial reaction products are not present in 
large enough quantities (8, 13). 
The reason why the genomic bovine DNA amplified a 200-bp 
segment whereas bovine cDNA amplified a 960-bp segment might 
be that some intervening sequence is present in the PEPCK gene 
that is transcribed but that is not present in mature mRNA. 
Secondary structure formation may prevent binding to RNA (5), 
which would be excluded if cDNA were used. Although the 
initial aim of this study was to generate a homologous probe 
for Northern hybridizations, the success attained with PGR 
prompted further sequencing of the amplified fragments and 
revealed that the sequences amplified in both cases (genomic 
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and cDNA) were almost identical except for a possible 
frameshift occurring between base 109 and 258 of the 
homologous region. The observation that this frameshift is 
not continuous throughout the amplified cDNA indicates that 
the protein produced from the frameshifted sequence would not 
necessarily be entirely different from rat protein, as would 
be the case if the frameshift encompassed the entire amplified 
sequence. 
Because the entire gene was not sequenced and because the 
region selected for amplification was at slightly different 
locations in the rat, chicken, Saccharomvces cerevisiae. and 
Drosophila melanoaaster PEPCK genes, it was not possible to 
give specific base locations of the amplified bovine PEPCK 
segment on the PEPCK gene. The fact that bovine genomic DNA 
amplified a 200-bp piece and bovine cDNA amplified a 960-bp 
piece suggests that probably a secondary structure formation 
prevents anything but the most homologous sequences from 
binding RNA. Genomic DNA might contain some intervening 
sequence that is transcribed but not found in mature mRNA that 
causes the binding of genomic DNA to be limited to 200-bp 
while the cDNA can bind the 960-bp product. The greater 
homology obtained at the 5' end of the amplified sequence 
suggests that these regions may be highly conserved, being 
closer to the functional parts of the molecule such as the 
catalytic sites. 
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Further research indicated is the complete sequencing of 
the bovine PEPCK gene, and comparisons of the bovine gene with 
other species to identify homologous regions. The fragment of 
bovine PEPCK cDNA amplified in this experiment could be used 
for Northern hybridizations of bovine RNA and also perhaps 
could be used as a probe to screen a bovine genomic or cDNA 
library to pick out parts of the bovine PEPCK gene. Another 
possible use for the bovine PEPCK cDNA amplified by using PCR 
would be as a primer for further PCR reactions to sequence 
other regions of the PEPCK genome in cows. Knowing the 
sequence of bovine PEPCK genome would enable mapping of splice 
sites and other functional areas of the molecule. Use of such 
amplified PCR products to prime reactions using pig or turkey 
DNA as templates would be a good way to compare homology 
between these species. Sequencing of these PCR products then 
would give a clearer understanding of the conserved regions 
present on the PEPCK gene. 
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GENERAL SUMMARY 
For many generations, cows have been bred and fed so that 
they have become a biological "factory" capable of producing 
enormous quantities of milk. An unwanted by-product of all 
the specializations used to cause them to produce more milk by 
genetic manipulation and by feeding highly digestible grains 
is their occasional inability to sufficiently regulate 
metabolic processes. This is especially true during the early 
postpartal period following the birth of a calf as milk 
production is initiated and reaches a peak amount. The 
metabolic demands of the initial peak of lactation are so 
great that cows must use body reserves to sustain milk 
production. In terms of their metabolism, they may be in 
negative energy balance while paradoxically consuming all the 
feed they can contain. This sequence of events sometimes 
leads to the development of a major metabolic disorder known 
as lactation ketosis. 
Almost all cases of lactation ketosis can be explained by 
the inability of the cow to satisfy her requirements for 
glucose, by a greatly increased mobilization and utilization 
of fatty acids, or by a combination of both changes. Because 
ruminants absorb only a small proportion of their glucose 
needs directly from the digestive system, they must depend to 
a great extent on gluconeogenesis by liver or kidney to 
produce the required glucose. The most important precursors 
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of glucose are propionate, lactate, and some amino acids. As 
cows are "pushed" for greater milk production, the cow has to 
either limit her milk production or put herself in negative 
energy balance. Because a cow has only a small body reserve 
from which to synthesize glucose, energy has to be provided by 
other processes. If ketone bodies accumulate in blood faster 
than they can be removed, then ketosis develops. Krebs (12) 
explained the excessive ketogenesis as a consequence of 
increased gluconeogenesis and hence decreased availability of 
oxaloacetate for oxidation of the increased amount of fatty 
acids via the citric acid cycle. Ketogenesis is greatest when 
the cows approach peak yield and are consequently dependent on 
an intense gluconeogenesis for lactose synthesis. 
Recently, however. Mills et al. (14) observed that the 
gluconeogenic capacity of liver slices decreased significantly 
during ketosis. They observed a uniform 66% decrease in 
gluconeogenesis from propionate, lactate, and gluconeogenic 
amino acids, which suggested a regulation of gluconeogenesis 
at the oxaloacetate to phosphoenolpyruvate stage. Baird et 
al. (2) concluded that the decrease in concentrations of 
gluconeogenic intermediates in spontaneous ketosis is the 
result of an imbalance between the supply of gluconeogenic 
precursors and the demand for glucose. Mills et al. (13) also 
showed a decrease in hepatic citrate concentrations during 
ketosis when compared with prepartal and recovery stages. 
These changes would cause increased ketogenesis, which could 
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be an important turning point in the development of ketosis. 
Does ketogenesis increase because of decreased activity 
of PEPCK and hence decreased gluconeogenesis? Indeed, from 
the present study, it has been observed that relative 
concentrations of PEPCK mRNA and the corresponding PEPCK 
protein in the FRBD groups were significantly less than in 
controls during the time that the clinical signs of ketosis 
become evident. These decreases suggest that expression of 
the PEPCK gene may in some way be related to development of 
ketosis. Furthermore, our results indicated that expression 
of the PEPCK gene is regulated at the transcriptional rather 
than at the translational level. 
Hormonal regulation of ketogenesis involves insulin, 
glucagon, and growth hormone (GH) (2). Decreased insulin and 
increased GH stimulate lipolysis and increase NEFA release 
into blood. Conversely, glucagon is gluconeogenic and 
stimulates lipolysis (21). Insulin depresses PEPCK activity 
in liver, whereas glucagon stimulates it through cAMP. 
Gluconeogenesis increases during lactation; hence, insulin 
concentrations decrease. These decreased insulin 
concentrations allow PEPCK activity to increase. 
If PEPCK activity decreases as signs of clinical ketosis 
become evident, it is possible that some aberration in the 
gene causes a decrease in PEPCK synthesis. Intracellular 
concentrations of mRNA can be changed by three mechanisms (1): 
(a) change in rate of synthesis, (b) change in rate of 
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degradation, and (c) modification of messenger activity or 
availability (storage of mature mRNA in a protein complex 
before initiating protein synthesis or modification of the 
mRNA in cytosol). Tilghman et al (20) verified that major 
changes of the amount of PEPCK in liver of rats was the result 
of changes in synthesis rate. 
No one has detected any effect of hormones on PEPCK 
degradation (8, 20). Accordingly, the observation in the 
present study that relative PEPCK mRNA and protein changes 
occur in parallel suggest that changes are regulated at the 
transcriptional rather than at the translational level. This 
suggestion is supported by lynedjian et al. (11) who observed 
that amounts of mRNA and PEPCK synthesis in liver of rats 
changed in parallel, and there were no untranslated pools of 
PEPCK mRNA whose translation could be stimulated by cAMP. 
Thus, the relative decrease in amounts of PEPCK mRNA during 
ketosis must be the result of a decreased rate of synthesis. 
To propose a mechanism for decrease of PEPCK gene 
expression as a possible cause of ketosis development, it is 
necessary to understand the sites of PEPCK mRNA regulation. 
Much research has been done upon cAMP regulation of PEPCK mRNA 
synthesis (17). Regulation of PEPCK mRNA synthesis is 
possible at the level of transcription when DNA is transcribed 
to heterogenous nuclear RNA (hnRNA), at the level of 
processing of the hnRNA to mature mRNA, at the level of mRNA 
degradation, or at the level of translation of the mRNA to 
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protein. 
There is indirect evidence that cAMP regulates PEPCK 
synthesis by altering the rate of translation of specific 
mRNA, which increases translational efficiency and hence rate 
of protein synthesis (21). Translation, however, does not 
seem to be the primary site of cAMP action on PEPCK synthesis, 
lynedjian et al. (11) proposed that cAMP regulated PEPCK mRNA 
at the level of transcription. Translation stabilizes this , 
mRNA and maintains the amounts in liver (17). The hypothesis 
that PEPCK mRNA is regulated primarily at the transcriptional 
level in ketosis is supported further by Sasaki et al. (19), 
who suggested that the primary action of insulin in the 
regulation of PEPCK synthesis is exerted at the level of mRNA 
transcription and by Bartels et al. (4) who indicated that 
PEPCK activity and enzyme protein were regulated mainly at the 
pretranslational level. Again, these findings support the 
conclusion that the relative decrease in PEPCK mRNA during 
ketosis must be the result of a decreased rate of synthesis. 
During ketosis, insulin concentrations are suppressed, 
gluconeogenesis is decreased, oxaloacetate is in short supply 
for the TCA cycle, and nonesterified fatty acids (NEFA) abound 
in blood. Evidence from other species suggests that the rate 
of hepatic ketogenesis from NEFA is determined both by rate of 
supply of NEFA and the carbohydrate status of the liver (10). 
As long as the rate of gluconeogenesis continues to be 
elevated, the cow can maintain body homeostasis. When she 
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starts using enormous amounts of her triacylglycerol reserves 
for energy, she starts becoming ketotic. Could the decrease 
in PEPCK gene expression be responsible for this change? 
Maybe it is necessary to use more triacylglycerol reserves for 
energy because glucose concentrations decrease at ketosis 
because of decreased PEPCK activities. More fatty acid 
mobilization means more hepatic acetyl CoA, and it is possible 
that, even though PEPCK activity is decreased, the 
oxaloacetate available for citric acid cycle oxidation cannot 
use all the acetyl CoA produced. This, in turn, leads to 
increased ketogenesis and consequently ketosis. 
other possible reasons for decreased PEPCK concentrations 
during ketosis could be (3); (a) a decreased availability of 
oxaloacetate (OAA) because of a low OAA to malate ratio in the 
mitochondria, (b) a shift in the intramitochondrial redox 
potential or NAD+/NADH ratio, or (c) a lack of precursors such 
as propionate. 
It seems that PEPCK concentrations change during ketosis 
because of a decrease in the rate of PEPCK enzyme synthesis. 
As stated earlier, some possible explanations for this 
decreased synthesis rate could be inhibition of transcription 
by some unknown factor, a block in processing of hnRNA to 
mRNA, a prevention of transport of mRNA from nucleus to 
cytosol, or a degradation of the mRNA itself in the cytosol. 
It is important to remember that FRBD cows have less hepatic 
PEPCK mRNA than control cows. Because relative PEPCK mRNA 
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concentrations increase in OFRBD cows when cows recover from 
ketosis, the effect of any inhibitors of transcription must 
not be permanent or irreversible. The hypothesis of a 
transcriptional inhibitor during ketosis is supported by 
Faliks et al. (7), who observed that the decay of PEPCK mRNA 
upon treatment with insulin or cordycepin was the result of a 
decrease in functional mRNA. They suggested that a general 
rapidly turning over inactivating system of mRNA may be 
present in rat liver, and it may involve a peptide factor 
because inhibitors of protein synthesis block the system. 
Such a factor also may exist in cow liver, which causes PEPCK 
mRNA concentrations to be less in ketotic cows. Regulation of 
the system or factor might be of great significance in 
cellular regulation of translatable mRNA. 
Although highly unlikely, the low insulin concentrations, 
to which the PEPCK gene is very sensitive (6), could regulate 
reciprocally the gene during development of ketosis. It has 
been observed that PEPCK synthesis may be regulated through 
template concentrations (17). The turnover of PEPCK mRNA is 
very rapid, and thus the processing of nuclear hnRNA to mature 
PEPCK mRNA also is very rapid; likewise, the half life of 
PEPCK mRNA seems to be very short, about 40 min (9). Because 
no known existing pool of PEPCK mRNA is available, PEPCK mRNA 
rapidly decreases if mRNA synthesis is decreased. 
If grain is overfed during late lactation, many cows 
become obese. Furthermore, obesity contributes to the 
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development of ketosis also through increased fatty liver 
development (5, 18) and elevated triacylglycerol to glycogen 
ratio (>2 by weight). Cows that are obese at calving are 
subject to a complex of metabolic diseases called the "fat 
cow syndrome" (15). In one high-incidence herd, morbidity was 
82% and mortality was 25% (16). Thus, the negative 
correlation of triacylglycerol to glycogen ratio with relative 
changes in concentrations of PEPCK mRNA and PEPCK protein 
obtained in this study strengthens the hypothesis that the 
PEPCK gene may be involved in the development of ketosis. 
The specific aim of the present study was to map out the 
pattern of change of PEPCK gene expression during early 
lactation in the dairy cow, with specific reference to the 
time of development of ketosis. The results indicated that 
PEPCK mRNA and PEPCK protein both changed relatively in 
parallel during early lactation of the dairy cow, as borne out 
by the correlation (P<0.001) between relative changes in 
concentrations of PEPCK mRNA and PEPCK protein (r = 0.44). 
The trend of change for both variables seems to be a 
progressive increase up to about day 35 postpartum, a dramatic 
drop around day 42 postpartum in the FRBD cows, when the 
clinical symptoms of ketosis become evident, and a further 
decrease in concentrations during the recovery period from 
ketosis, except for the obese FRBD cows. Because relative 
differences in PEPCK mRNA and PEPCK protein change in 
parallel, the cause of these changes in expression during 
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lactation seems to be transcriptional rather than 
translational. A negative correlation (P>0.05) of TG to 
glycogen ratio with PEPCK mRNA (-0.20) and with PEPCK protein 
(-0.18) also was obtained, suggesting a role for the PEPCK 
gene in development of ketosis. 
Further research on the relationship of PEPCK to the 
etiology of fatty liver and lactation ketosis, such as in 
vitro transcription studies and PEPCK enzyme activity 
measurements, would give a clearer picture of PEPCK gene 
expression during ketosis development. A fuller understanding 
of regulation of the PEPCK gene also will require further 
study on the structure and organization of the bovine PEPCK 
gene. It is probable that intervening sequences present in 
the gene are transcribed but are not found in mature mRNA, 
which could act in regulation of expression. The role of such 
factors in the development of ketosis will require further 
research if we are to completely prevent this metabolic 
disease. 
In the present study, an attempt also was made to amplify 
part of the bovine PEPCK gene sequence. A comparison of known 
PEPCK sequences was made, and a homologous region from rat, 
chicken, yeast, and Drosophila melanoaaster was selected for 
use in the polymerase chain reaction (PCR). Sequences 
selected for priming the reaction from bovine genomic DNA were 
based upon rat sequences. As an additional experiment, the 
first strand of bovine cDNA was generated from bovine mRNA, 
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and the same primers were used for PGR. Genomic bovine DNA 
was able to serve as a template for amplification of,a 200-bp 
fragment of DNA, whereas bovine cDNA served as a template for 
amplification of a 960-bp region that was almost identical to 
the rat PEPCK cDNA sequence. 
While the original aim of the study was to generate 
homologous probes for hybridization, the success attained 
prompted further sequencing of the amplified fragments and 
revealed that the sequences amplified in both cases (genomic 
and cDNA) were almost identical except for a possible 
frameshift occurring between bases 109 and 258 of the 
homologous region. Because the entire PEPCK gene was not 
sequenced and because the region selected for amplification 
was at slightly different locations in the PEPCK gene of the 
animals studied, it was not possible to give base locations on 
the gene of the amplified fragment of bovine PEPCK. 
The observation that bovine genomic DNA amplified a 200-
bp piece and bovine cDNA amplified a 960-bp piece suggests 
that a secondary structure formation may prevent anything but 
the most homologous sequences to bind RNA. Also, genomic DNA 
might contain some intervening sequence that is transcribed 
but is not found in mature mRNA that causes binding of genomic 
DNA to be limited to 200 bp whereas the cDNA can bind 960 bp. 
Further research should involve complete sequencing of 
the bovine PEPCK gene and subsequent comparisons with other 
species to identify homologous regions. Further study on 
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PEPCK mRNA secondary structure also might enable 
identification of problems caused while trying to conduct 
hybridizations and other molecular research with this gene. 
The fragment of bovine PEPCK cDNA amplified in this 
experiment could be used for Northern hybridizations of bovine 
RNA and perhaps could be used also as a probe to screen a 
bovine genomic or cDNA library to pick out parts of the bovine 
PEPCK gene. Another possible use for bovine PEPCK cDNA 
amplified by using PCR would be as a primer for further PCR 
reactions to sequence other regions of the PEPCK genome in 
cows. Knowing the sequence of bovine PEPCK genome would 
enable mapping of splice sites and other functional areas of 
the molecule. Utilization of such amplified PCR products to 
prime reactions using pig or turkey DNA as templates would be 
a good way to compare homology between these species. 
Sequencing of these PCR products would then give a clearer 
understanding of the conserved regions present on the PEPCK 
gene. 
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APPENDIX A: SOLUTIONS FOR RNA ANALYSES 
All glassware for RNA work must be baked at 3 00°C 
overnight, and, as far as possible, all solutions must be 
autoclaved. Only diethylpyrocarbonate (DEPC)-treated water can 
be used for making solutions. All reagents not specifically 
indicated otherwise were purchased from Sigma Chemical Company, 
St.Louis, MO. 
I. Solutions for RNA isolation 
a. 10% Sarkosyl (autoclaved). 
b. Guanidinium thiocyanate (GTC) solution: Stirred 125 g of 
guanidine thiocyanate to dissolve in 146.5 ml sterile 
water while heating at 65°C for 5 to 10 minutes. 
Filtered solution through Whatman 40 circular filter paper in 
vacuum in hood. 
c. Sodium acetate, 2 M (pH 4.0); Dissolved 16.406 g of 
anhydrous sodium acetate in 50 ml sterile water, added 50 ml 
of concentrated HCl to adjust for pH, and then autoclaved. 
d. Sodium citrate, 0.75 M (pH 7.0): Dissolved 69.3 g of sodium 
citrate in 100 ml of DEPC-water, adjusted to pH 7.0 
with concentrated HCl, and autoclaved. 
e. 0.5% Sodium dodecyl sulfate (SDS, Sodium lauryl sulfate). 
f. 70%, 75% and 95% ethanol solutions were prepared and stored 
at -20'C. 
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g. jS-Mercaptoethanol. 
h. Stock GTC solution; This was prepared just before use by 
mixing the GTC solution in (b) with 8.8 ml of 0.75 M sodium 
citrate, and 13.2 ml of 10% Sarkosyl, so the final 
concentration was 4 M GTC, 25 mM sodium citrate and 0.5% 
Sarkosyl. 
i. Solution D: Just before use, jS-mercaptoethanol was added to 
stock GTC solution (0.36 ml for every 50 ml GTC stock 
solution). 
j. Loading buffer for RNA preparations: This was made by mixing 
the following: 0.72 ml formamide, 0.16 ml of 10 X 
MOPS buffer (see Ila) , 0.26 ml of formaldehyde (37%), 0.18 ml 
of water, 0.1 ml of 80% glycerol, and 0.08 ml of bromophenol 
blue (saturated solution). Made this solution fresh every 
1-2 weeks and discarded when color changed, or made 10 ml 
and stored 0.5 ml aliquots at -20*C. 
II. Solutions for Northern hybridizations 
a. {3-[N-morpholino]propanesulfonic acid (MOPS)} buffer (10 X): 
This was prepared as follows: Dissolved 41.86 g of MOPS, 
4.1 g of sodium acetate, and 3.72 g of disodium EDTA in 
1 liter of water, adjusted pH to 5.5-6.0 (autoclaved). The 
working solution is l X MOPS. 
b. Denhardt's solution (50 X): This was made by mixing the 
following reagents: 5 g of Ficoll, 5 g of 
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polyvinylpyrrolidone, and 5 g of bovine serum albumin in 
500 ml of water. 
c. Prehybridization solution; This consisted of the following 
solutions: 12.5 ml of 1 M KPO4 (pH 7.4), 125 ml of 20 X SSC 
(see lie), 25 ml of 100 X Denhardt's solution, 250 ml 
of 100% formamide, and 82.5 ml of sterile DEPC water, diluted 
to 500 ml. 
d. Hybridization solution: This is the same as prehybridization 
solution with 10% dextran sulfate added. 
Note: 5 ml of salmon sperm DNA (sonicated) needs to be added 
to the prehybridization and hybridization solutions , but my 
experience is that adding them just before doing the actual 
experiment ensures the best results. 
e. SSC buffer (20 X): This was prepared by dissolving 175.3 g 
of sodium chloride and 88.2 g of sodium citrate in 800 ml of 
sterile DEPC water. The pH was adjusted to 7.0 with a few 
drops of 10 N sodium hydroxide solution; the solution was 
diluted to 1 liter, and autoclaved. 
f. EDTA, 0.2 M (pH 8.0), autoclaved. 
g. Sterile DEPC water: Added 20 jul of DEPC to two liters of 
double distilled water and autoclaved after leaving for 12 
hours at room temperature. 
h. NaH2P04, 0.75 M (pH 3.5), autoclaved. 
i. Sonicated salmon sperm DNA. 
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j. Wash solution I: Made 100 ml by mixing together 10 ml of 
5% BSA, 200 ul of 0.5 M EDTA, 4 ml of 1 M NaH2P04, and 25 ml 
of 20% SDS. 
k. Wash solution II: Made 100 ml by mixing together 200 /il of 
0.5 M EDTA, 4 ml of 1 M NaH2P04, and 5 ml of 20% SDS. 
III. Solutions for extraction of mRNA usina columns 
ffor Northerns) 
This procedure was carried out by using mRNA separator 
columns purchased from Clontech Laboratories, Inc., Palo 
Alto, CA. The materials used were as follows: 
a. Oligo (dT)-cellulose spun columns. 
b. High salt buffer: This solution contained 10 mM Tris-HCl 
(pH 7.4), 1 mM EDTA, and 0.5 M NaCl. 
c. Low salt buffer: This solution contained 10 mM Tris-HCl 
(pH 7.4), 1 mM EDTA, and 0.1 M NaCl. 
d. Sample buffer: This solution contained the following 
reagents: 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, and 3 M NaCl. 
e. Elution buffer: This solution contained 10 mM Tris-HCl 
(pH 7.4) and 1 mM EDTA. 
f. Potassium acetate, 2 M (pH 5). 
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APPENDIX B: SOLUTIONS FOR DNA ANALYSES 
I. Solutions for Southern hybridization 
The solutions required in addition to the Northern 
hybridization solutions are the following; 
a. HCl, 0.25 M. 
b. A solution containing 0.5 N NaOH and 1 M NaCl. 
c. Tris-HCl, 0.5 M (pH 7.4). 
d. 3 M NaCl. 
e. SSC (10 X). 
II. Solutions for extraction of plasmid DNA from cells 
a. LB Broth (1 liter); The following reagents were mixed 
together: 10 g of Bacto tryptone, 5 g of yeast extract, 
10 g of sodium chloride, 15 g of Bacto agar, and 
100 /il/100 ml of tetracycline (these five reagents were 
purchased from Chemistry Stores, BlOl Gilman Hall, Iowa State 
University). 
b. Solution A: This solution contained 50 mM glucose, 25 mM 
Tris-Cl (pH 7.5), 10 mM EDTA (disodium salt), and 25 mg 
of lysozyme per 5 ml of solution. 
c. Solution B: This solution contained 0.2 N NaOH, and 
1% sodium lauryl sulfate. 
d. Solution C: This solution contained 5 M potassium acetate. 
e. LiCl/MOPS: This solution contained 5 M LiCl and 0.05 M MOPS 
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(pH 8.0). 
III. Solutions for resolution of DNA on agarose aels 
a. Tris acetate buffer (TAE, 50 X): This solution contained 
242 g of Tris base, 57.1 ml of glacial acetic acid, and 100 
ml of 0.5 M EDTA (pH 8.0), diluted to 1 liter with distilled 
water. The working solution is 1 X TAE (0.04 M TAE,0.001 M 
EDTA). 
b. Tris borate buffer (TBE, 5 X); This solution contained 54 g 
of Tris base, 27.5 g of boric acid, and 20 ml of 0.5 M EDTA 
(pH 8.0), diluted to 1 liter with distilled water. The 
working solution is 0.5 X TBE (0.045 M TBE, 0.001 M EDTA). 
c. Loading buffer I (6 X): This solution contained 
0.25% of bromophenol blue and 40% (w/v) sucrose in water. 
The solution was stored at 4°C. 
IV. Solutions for large scale preparation of plasmid DNA 
(cleared Ivsate method) 
Unless otherwise stated, all solutions were made up in 
distilled water. 
a. Tris, 1 M (pH 8.0): Dissolved 60.57 g of Tris/500 ml and 
autoclaved. 
b. EDTA, 0.5 M (pH 8.0): Dissolved 73.06 g of EDTA/500 ml and 
autoclaved. 
d. TES buffer; This solution contained 30 mM Tris (pH 8.0) 
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(30 ml Of 1 M Tris/liter) (autoclaved), 50 raM NaCl 
2.92 g/liter), and 5 mM EDTA, pH 8.0 (10 ml of 0.5 M 
EDTA/liter). 
e. TE buffer: This solution contained 10 xnM Tris (pH 8.0) 
10 ml of 1 M Tris /liter) (autoclaved), and 1 mM EDTA, pH 8.0 
(2 ml of 0.5 M EDTA/liter). 
f. TE + 25% sucrose: This solution contained 25 g of sucrose 
(filter sterilized) and TE (up to 100 ml) . The solution can 
be stored at -20°C. 
g. 10% Triton X-100: This solution contained 10 mM Tris, pH 8.0 
(1 ml of 1 M Tris per 100 ml), which was filtered into other 
solutions. 
h. Triton X-100 (10 ml per 100 ml). 
i. Triton lytic mix; This solution contained 0.1% Triton X-100 
(1 ml filtered 10% Triton/100 ml) (autoclaved), 62.5 mM EDTA, 
pH 8.0 (12.5 ml of 0.5 M EDTA/ 100 ml), 50 mM Tris, pH 8.0 
(5 ml of 1 M Tris/ 100 ml). 
j. 1% Lysozyme: This solution was stored in 1 ml aliquots at 
-20°C, (0.1 g/10 ml) and filter sterilized. 
k. LB Broth. 
1. NaCl, 5 M: Dissolved 146.1 g of NaCl/500 ml and autoclaved. 
m. Isopropanol saturated with 5 M NaCl: This solution 
contained isopropanol (about 500 ml/1 liter), and 5 M NaCl 
(about 300-500 ml) or enough to get two phases. It is 
acceptable if some NaCl precipitates out. Isopropanol is the 
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top phase. The solution was placed in a sterile bottle, 
n. Ethidium bromide (EtBr), 10 mg/itil: Concentrated stock (made 
in EtBr bottle) was diluted with sterile water to get 10 ml 
of 10 mg/ml and stored in a brown or foil-covered sterile 
bottle at 4'C. 
o. 75% Ethanol: This solution was made by dissolving 150 ml 
100% ethanol in 50 ml sterile water. Stored this and 
100% ethanol in sterile bottles at -20°C. 
p. Sodium acetate, 3 M; Dissolved 123.05 g of sodium 
acetate/500 ml and autoclaved. 
q. DNA loading dye (10 X) ; This solution contained 5 /il of 
glycerol, 0.37 g of Na^EDTA.2H2O, 0.1 g of SDS, 100 jtil of 
a 10% solution of bromophenol blue, and 4.9 nl of sterile 
water (total volume 10 /xl) . 
V. Solutions and procedure for c-Clone II cDNA svnthesis kit 
The kit used was obtained from Clontech Laboratories, Inc., 
Palo Alto, CA. The components of the kit were as follows; 
a. Oligo (dT)15 primer (lnq/nl). 
b. Random primer (0.3 fig/ixl). 
c. First strand buffer; This solution contained 500 mM Tris 
(pH 8.3), 100 mM dithiothreitol (DTT), and 100 mM magnesium 
chloride. 
d. dNTP mix (First strand); This solution contained 20 mM each 
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of dATP, dTTP, dCTP, and dGTP. 
e. Potassium chloride, 1 M. 
f. RNase inhibitor. 
g. AMV reverse transcriptase. 
h. Second strand buffer: This solution contained 500 laM 
potassium chloride, 50 mM ammonium sulfate, 25 mM magnesium 
chloride, 0.75 mM i3-NAD+, 100 mM Tris (pH 7.5), 0.25 ng/ml 
bovine serum albumin, and 0.20 mM each of dATP, dCTP, dGTP, 
and dTTP. 
i. E. coli DNA polymerase I. 
j. RNase H. 
k. T4 DNA Polymerase I. 
1. tRNA (25 ixg/iil). 
m. EcoRl methylase buffer (1 X); This solution contained 
100 mM sodium chloride, 100 mM Tris (pH 8.0) , 1 mM EDTA, and 
80 iM SAM (S-adenosyl methionine). 
n. EcoRl methylase. 
o. SI nuclease buffer (10 X): This solution contained 33 0 mM 
sodium acetate, 500 mM sodium chloride, and 0.3 mM zinc 
chloride. 
p. SI nuclease. 
q. SI nuclease stop solution: This solution contained 250 mM 
EDTA, and 1 M Tris (pH 8.0). 
r. Repair buffer (10 X): This solution contained 0.5 M Tris 
(pH 7.4), 70 mM magnesium chloride, and 100 mM DTT. 
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s. dNTP mix (Klenow): This solution contained 1 mM each of 
dATP, dCTP, dGTP, and dTTP. 
t. Klenow fragment (of DNA Polymerase I). 
u. EcoRl phosphorylated linkers (1 lig/til) . 
V. Ligation buffer (10 X) : This solution contained 500 mM Tris 
(pH 7.8), 100 mM magnesium chloride, and 50 mM DTT. 
w. 10 mM ATP. 
X. T4 DNA ligase. 
y. T4 RNA ligase. 
z. EcoRl buffer (5 X): This solution contained 250 mM Tris 
(pH 7.5), 50 mM magnesium chloride, and 500 mM sodium 
chloride. 
aa. EcoRl endonuclease. 
bb. Sterile deionized water. 
cc. EDTA, 0.2 M. 
dd. Ammonium acetate, 4 M. 
First strand synthesis 
1. The following reagents were combined in a sterile tube on 
ice: 10 jug of poly (A)+ mRNA, 10 /il of primer (oligo (dT) 15 
or random), and sterile water to a final volume of 36 nl. 
The contents were mixed, spun briefly to bring all 
contents to the bottom of the tube, and incubated in a 68'C 
water bath for 15 minutes. The tube was cooled slowly to 
42*C by allowing the water bath itself to cool while 
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containing the sample, which then was spun down briefly. 
2. When cool, the sample was placed back on ice, and the 
following reagents were added to it; 8.8 /il of first strand 
buffer, 4 nl of dNTP mix, 3.2 [il of 1 M KCl, 80 units of 
RNase inhibitor, 30 nCi a-^^P-dCTP (optional) , 200 units 
reverse transcriptase (20 units per microgram of mRNA), and 
sterile water to a final volume of 80 /il. The tube was 
incubated at 42°C for 45 minutes, and then EDTA to a 
concentration of 20 mM and water to a final volume of 
100 /il were added. 
3. The solution was extracted twice with phenol:chloroform, 
once with chloroform, and the top aqueous layer was 
precipitated with 25 /ig of tRNA for coprecipitation, and the 
pellet was spun and dried. 
Phenol: chloroform and chloroform extractions; 
1. Buffered phenol;chloroform was prepared as follows: 
Phenol was melted and equilibriated with an equal volume of 
sterile TNE (50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA) by 
mixing and letting stand to separate the phases. The top 
layer was removed and discarded. An equal volume of 
chloroform was added to the bottom (buffered phenol) layer, 
mixed thoroughly, and allowed to stand to separate the 
phases. The bottom layer contained the phenol;chloroform 
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and was stored at 4*C protected from light. 
2. For extraction, reaction sample volumes were brought up to 
100 fil with sterile deionized water, an equal volume 
(100 fJLl) of 1:1 phenol;chloroform was added to sample and 
mixed by gently rocking the tube back and forth several 
times. 
3. The tube was spun for two minutes in an Eppendorf 
microcentrifuge. The top aqueous layer was removed to a 
clean tube, and the interphase and lower phase were 
discarded. 
4. Steps 2 and 3 were repeated for the second phenol: chloroform 
extraction. 
5. An equal volume of chloroform was added to the aqueous layer 
and mixed by rocking the tube back and forth and spun for two 
minutes; then, the top aqueous layer was removed to a clean 
tube. 
Note; Some steps may require addition of tRNA for 
coprecipitation. This is added just before ethanol 
precipitation and after extractions. 
Ethanol precipitation; 
1. An equal volume of 4 M ammonium acetate was added to the 
sample (100 jul for most steps) and mixed gently. 
2. About 2.5 volumes (sample volume + salt volume x 2.5 = 500 /xl 
for most steps) of cold (-20'C) ethanol were added and mixed 
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by gently rocking the tube back and forth. 
3. The tube was placed at - 70*C for at least one hour. 
Recovery of sample: 
1. The sample was removed from the -70*C freezer and thawed 
until ethanol was liquid but still cold. 
2. The sample was centrifuged in a microfuge at full speed 
(15,000 rpm), preferably at 4'C, for 15 to 20 minutes. 
3. The ethanol was poured off while holding the tube with the 
pellet side up. 
4. The tube was spun briefly to bring all ethanol to the bottom 
of the tube, and this excess of ethanol was removed with a 
long, thin microcapillary tip, being careful not to disturb 
the nucleic acid pellet. 
5. The pellet was dried under vacuum for one to two minutes only 
(or let it air dry for 15 minutes). 
EcoRl methylase reaction: 
1. The pellet was resuspended in 45 ixl IX methylase buffer by 
gently pipetting up and down. 
2. Added 5 fil methylase enzyme to the tube, mixed gently and 
spun briefly. The tube was incubated at 37'C for one hour. 
3. Water was added to a final volume of 100 iil, and 
phenol:chloroform and chloroform extraction was done as 
described previously. 
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4. Added 150 fil tRNA to the tube and then precipitated as 
described previously; the pellet then was spun and dried. 
Note: The increased amount of tRNA added at the end of the 
methylase step is a prerequisite for the SI nuclease step that 
follows. The tRNA will prevent over-cutting of the cDNA as the 
enzyme will be active mostly on the hair-pin loops of the tRNA. 
SI Nuclease: 
1. The pellet was resuspended in 88 fil of sterile water by 
gently pipetting up and down, and 10 /il of lOX SI nuclease 
buffer was added. 
2. The SI nuclease enzyme was diluted to one unit per microliter 
in sterile water just prior to using; then two units (2 jil) 
were added to contents at the bottom of the tube. 
3. The tube was incubated in a 37'C waterbath for exactly five 
minutes and immediately placed on ice; then, 5 /il of Si 
nuclease stop solution were added and mixed thoroughly. 
4. After extracting and precipitating as described previously, 
the pellet was spun and dried. 
Klenow reaction: 
1. The pellet was resuspended in 7 /il sterile water by gently 
pipetting up and down. 
2. The following then were added: l /il dNTP mix, 1 /il 10 X 
repair buffer, and five units (1 /il) Klenow enzyme. After 
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mixing and briefly spinning, the tube was incubated at 22*C 
for 30 minutes, and then the mixture was heated at 68'C for 
10 minutes. 
3. The tube was cooled on ice and then spun briefly to bring the 
contents of the tube to the bottom. 
4. At this step, the cDNA was spun down, dried, and used for 
polymerase chain reaction. 
cDNA quantitation: 
The yield of cDNA was determined by the method of Sambrook 
et al. (1989). 
166 
APPENDIX C: SOLUTIONS FOR PROTEIN ANALYSES 
I. Solutions for protein extraction 
a. Running gel; The solution contained 3.75 ml of 3 M Tris 
(pH 8.8), 0.3 ml of 10% SDS, 12 ml of acrylamide 
bisacrylamide (30:0.8), 13.8 ml of water, 100 fil of 10% APS 
(ammonium persulfate) , and 13 /il of TEMED (N,N,N,N'-
tetramethylethylenediamine). 
b. Stacking gel: The solution contained 2 ml of acrylamide 
bisacrylamide (30:0.8), 1.25 ml of 1 M tris (pH 6.8), 100 ni 
of 10% SDS, 6.6 ml of water, 70 (il of 10% APS, and 11 jul of 
TEMED. 
c. Tris-HCl, 3 M, pH 8.8 (for running gel). 
d. Tris-HCl, 1 M, pH 6.8 (for stacking gel). 
e. Running buffer; The following reagents were mixed for 
1 liter of 10 X stock: 30.3 g of Tris base, 144 g of 
glycine, 10.0 g SDS, and water. Diluted 1:10 in water for 
use. 
f. Acrylamide-bisacrylamide solution (30:0.8); The solution 
contained 3 00 g of acrylamide, 8 g of N,N'-methylene-bis 
-acrylamide, and water to approximately 800 ml. While 
stirring, approximately 1 teaspoon activated charcoal was 
added and stirring was continued for 2-4 hours. The solution 
was then filtered through Whatman # 1 paper, 1 liter of water 
was added to make up the final volume, and the solution was 
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filtered through 0.45 (jl cellulose acetate or cellulose 
nitrate filter. 
Note; The filters will clog, so it may be necessary to change 
them once or twice during this filtration. The solution can be 
stored at 4*C in a brown bottle, and is stable for 1-2 months. 
g. 10% ammonium persulfate in water (APS): This solution 
consists of 1 g of APS dissolved in 10 ml water, in a 15 ml 
blue topped tube. About 10 ml of solution was prepared at a 
time and stored at 4*C. This solution was stable for several 
weeks. 
h. 10% SDS. 
i. Coomassie Blue solution: Coomassie Brilliant Blue R250 
(0.25 g) was dissolved in 90 ml of methanol;water (1:1 v/v) 
and 10 ml of glacial acetic acid and filtered through 
Whatman No.l filter paper to remove any particulate matter. 
II. Solutions for Western analvses 
a. Transfer buffer for SDS gels; This solution contained 192 mM 
glycine, 25 mM Tris base, and 20% methanol. The following 
reagents were mixed; 57.7 g of glycine, 12.1 g of Tris base, 
800 ml methanol, and 3200 ml water. The solution was kept 
cold. 
b. Blocking, hybridization and rinsing solutions (RB); This 
solution contained 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 150 ml 
of NaCl, and 0.1% Triton X-100. The following reagents were 
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mixed; 988 ml of water, 1 ml of 100% Triton X-100, 10 ml 1 M 
Tris-HCl (pH 8.0), and 8.75 g of NaCl per liter. 
c. For blocking and antibody incubation some 2% RB in BSA was 
prepared (dissolved 1 g BSA in 50 ml RB; the new solution was 
RB-BSA). 
d. For rinsing after '"l-protein A treatment, some RB (1 M) in 
NaCl was prepared (dissolved 49.6 g NaCl in 1 L RB; the new 
solution was RB-Hisalt). 
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APPENDIX D: RNA AND DNA ANALYSES 
I. RNA isolation 
The liver biopsy samples were stored in liquid nitrogen as 
soon as they were extracted, transferred to the - 80'C freezer 
in the laboratory, and stored there until analyses were 
conducted. Isolation of RNA from frozen liver tissue was 
performed by the method of Chomczynski and Sacchi (3). 
1. Frozen liver tissue (0.1 g) was minced on ice, homogenized 
(at room temperature) with 1 ml of solution D (see Appendix 
A) in a Polytron homogenizer (Brinkmann Homogenizer Model FT 
10-35 from Sybron/Brinkmann, Brinkmann Instruments Co., 
Westbury, NY) and subsequently transferred to a 4-ml 
polypropylene tube. 
2. Sequentially, 0.1 ml of 2 M sodium acetate (pH 4), 1 ml 
of buffer saturated phenol (obtained from Bethesda Research 
Laboratories Life Technologies, Inc., Gaithersburg, MD), and 
0.2 ml of chloroform-isoamyl alcohol mixture (49:1) were 
added to the homogenate, with thorough mixing by inversion 
after the addition of each reagent. 
3. The final suspension was shaken vigorously for 10 seconds 
and cooled on ice for 15 minutes. 
4. Samples were then centrifuged at 10,000 x g for 20 minutes at 
4*C. After centrifugation, RNA was present in the aqueous 
phase, whereas DNA and proteins were present in the 
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interphase and phenol phase. 
5. The aqueous phase was transferred to a fresh tube, mixed 
with 1 ml of isopropanol, and then placed at -20'C for at 
least one hour to precipitate RNA. 
6. Sedimentation at 10,000 g for 20 minutes was again 
performed at 4*C. 
7. The resulting RNA pellet was dissolved in 0.3 ml of solution 
D, transferred into a 1.5 ml Eppendorf tube and 
precipitated with 1 volume of isopropanol at -20°C for 1 
hour. 
8. After centrifugation in an Eppendorf centrifuge (Fisher 
Model 59A Microcentrifuge, purchased from Fisher Scientific, 
Pittsburgh, PA) for 10 minutes at 4*C, the RNA pellet was 
resuspended in 75% ethanol and sedimented. 
9. The sample was then vacuum dried in a Speed Vac Concentrator 
(Model SVC-IOOH, purchased from Savant Instruments Inc., 
Farmingdale, NY) for 15 minutes and dissolved in 100 nl of 
diethyl pyrocarbonate (DEPC) - water. 
Resolution of RNA 
RNA was resolved on a 1% agarose gel (Seakem GTG Agarose 
purchased from FMC Bioproducts, Rockland, ME) to test for 
quality of RNA (presence of intact 28S and 18S bands) . The 
apparatus used was a Model H5 Horizontal Gel Electrophoresis 
Apparatus and a Model 250 Electrophoresis Power Supply (both 
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purchased from BRL Life Technologies, Inc., Gaithersburg, MD). 
RNA was resolved and photographed by using a UV Transilluminator 
(obtained from UVP Inc., San Gabriel, CA). 
II. Slot-blot analysis of RNA 
1. Once good quality RNA was ascertained, the O.D. was read on 
a spectrophotometer at 260 and 280 nm (Gilford Model 2600, 
obtained from Gilford Instrument Labs Inc., Oberlin, OH). 
2. RNA was then prepared as follows; 100 fj,l sample + 60 jixl 
20 X SSC + 40 Hi formaldehyde were heated at 65'C for 15 
minutes, placed on ice immediately, and then applied on a 
slot blot apparatus in serial dilution, ranging from 100 jug 
to 6.25 jug. 
3. The apparatus used was a Bio-Dot SF Assembly (Bio-Rad 
Laboratories, Richmond, CA). The apparatus and gasket were 
cleaned and dried before assembly. The membrane support 
plate was placed into position in the vacuum manifold and 
the sealing gasket was placed on top of it. 
4. Three sheets of Bio-Dot SF filter paper were soaked in 
20 X SSC and placed on the membrane support. 
5. The nitrocellulose membrane (S&S pure nitrocellulose, 
0.45 {Mm pore size, from Schleicher and Schuell, Keene, NH) 
was pre-wetted by slowly sliding it at a 45* angle into 
wetting solution (20 X SSC). Complete wetting of the 
membrane was needed for proper drainange of solutions. 
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6. After removing the membrane from solution, it was laid on 
the filter paper in the apparatus so that it extended over 
the edges of the filter paper. The membrane should not be 
exposed to the atmosphere by extending beyond the edge of 
the gasket after the apparatus is assembled. 
7. Any air bubbles trapped between the membrane and filter 
paper were removed. 
8. The sample template was then placed on top of the membrane. 
The guide pins insured that the template would be aligned 
properly. The four screws were tightened using a diagonal 
crossing pattern to insure even application of pressure on 
the membrane surface. 
9. The vacuum was turned on, and the three-way valve was set to 
apply vacuum to the apparatus. With vacuum applied, the 
tightening process was repeated using the diagonal crossing 
pattern. Tightening while vacuum is applied insures a tight 
seal, preventing cross contamination between slots. Failure 
to tighten screws during application of vacuum before 
starting the assay may lead to leaking between the walls. 
10. The flow valve was adjusted so that the vacuum manifold was 
open to atmospheric pressure. 
11. The buffer (100 jul) was added to all sample wells. Addition 
of buffer is necessary to réhydraté the membrane following 
the vacuum procedure, and if this step is not performed 
before applying samples, assay results will show halos or a 
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weak detection signal. 
12. Buffer was then removed from the wells by vacuum. As soon 
as the buffer solution drained from all the wells, the flow 
valve was adjusted so that the unit was exposed to 
atmospheric pressure and the vacuum was disconnected. 
13. Samples were then applied to the wells in serial dilution. 
Preparation of probe 
The next step was to label the probe, using the Random 
Primer DNA Labelling kit from Boehringer Mannheim Corporation 
Biochemical Products (Indianapolis, IN). 
1. About 40 ng of rat liver cytosolic PEPCK cDNA (kindly 
supplied by Dr. R. W. Hanson of Case Western Reserve 
University, Cleveland, Ohio) was heated at 95°C for 
10 minutes; and 7 fil of sterile DEPC water and 2 p.! of 
reaction mix were added, and the mixture was placed on ice 
immediately. 
2. Then, 1 111 each of dATP, dTTP, and dGTP; 5 /il of radioactive 
dCTP (a-^P dCTP, specific activity of 3000 Ci/mmol, from NEN 
Research Products, Du Pont Company, Biotechnology Systems, 
Wilmington, DE), and 1 jiil of Klenow enzyme were added to the 
cooled mixture, which was incubated at 37"C for one hour. 
3. The reaction was stopped by adding 2 jul EDTA (0.2 mole/1, 
pH 8.0). Sterile DEPC water (28 /il) was added and the tube 
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contents were mixed by spinning in a tabletop microfuge. 
4. The efficiency of labeling was quantified by scintillation 
counting and confirmed by thin layer chromatography (TLC). 
5. To purify the probe, Select-D, G-50 columns from 5'-2', Inc. 
were used (West Chester, PA). The column was taken from 
4°C, where it was stored and inverted several times to 
fully resuspend the gel. 
6. First, the top closure was removed, then the bottom closure. 
The buffer (STE buffer; 10 mM Tris, 1 mM EDTA, 0.1 M NaCl, 
pH 8.0) was allowed to drain from column. 
7. The column was then placed in a collection tube and 
centrifuged at 1100 x g (RCF about 2.5 in microfuge) for two 
minutes, or until the gel shrunk. 
8. The collection tube was then discarded and buffer was 
collected. 
9. A 50 Hi sample then was applied carefully to the center of 
the shrunken gel bed. The column was placed in a second 
collection tube and centrifuged at 1100 x g for 4 minutes. 
10. The labelled nucleic acid would be recovered in about 50 ijlI 
of STE buffer and the unincorporated label would be retained 
on the column. 
Probe quantification 
a. Scintillation counting 
The probe was quantified by using the scintillation counter 
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(Beckman LS 8000 Series Liquid Scintillation System, obtained 
from Beckman Instruments Inc., Palo Alto, CA). Samples of the 
probe (1 Ml each) before and after label separation were added 
to 10 ml scintillation cocktail (ScintiVerse BD) in disposable 
vials (both obtained from Fisher Scientific, Pittsburgh, PA). 
The program used for counting ^^P was Program 6, along with a 
reference background and standards. 
b. Thin layer chromatography 
The probe was checked doubly for efficiency of labeling by 
using 1 jul each of probe before and after separation of label to 
resolve for separation, by using thin layer chromatography. 
Precoated plastic TLC sheets (Polygram Cel 300 PEI, obtained 
from Sybron/Brinkmann, Brinkmann Instruments Company, Westbury, 
NY) were cut into strips and after 1 jul of probe was spotted on 
the bottom, were placed in a beaker containing 0.75 mM sodium 
dihydrogen phosphate (pH 3.5), and allowed to run for about 5 to 
7 minutes. The strip was dried, taped to Whatman 3 MM filter 
paper, and exposed to film for resolution. 
Prehvbridization and hybridization 
1. The nitrocellulose membrane was baked for two hours at 80*C 
in a vacuum oven to fix the RNA onto it. 
2. The next step in the analysis was prehybridization, where the 
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membrane was shaken at 42'C with 2.5 ml of 2X stock 
prehybridization solution and 2.5 ml of 100% formamide in a 
plastic Seal-a-meal bag (purchased from Dazey Corporation, 
KS) . 
3. Sonicated salmon sperm DNA, which had been denatured by 
heating at 95°C for ten minutes, was placed on ice and added 
to the blot. 
4. The bagged blot was shaken at 42°C for about four hours. 
5. Hybridization (6) consists of emptying out the 
prehybridization solution, and adding 2.5 ml of hybridization 
stock and 2.5 ml of 100% formamide. 
6. After 40 ng of probe and sonicated salmon sperm DNA were 
denatured at 95°C for 10 minutes and cooled immediately on 
ice, these were added to the bag with the blot and sealed. 
7. The blot was hybridized overnight (16 hours) at 42°C. 
Washing 
1. The blot was washed (always in 250 ml) twice at room 
temperature for 15 minutes in 1 X SSC and 0.5% SDS; twice at 
room temperature for 15 minutes in 0.25 X SSC and 0.5% SDS. 
2. The blot was bagged in a plastic Seal-a-meal bag and exposed 
to film at -80'C in the presence of Du Pont Cronex (Lightning 
Plus) intensifying screens (Cassling Diagnostic Imaging, 
Omaha, NE), for varying periods of time until the desired 
degree of exposure was achieved (14 hours). 
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III. Northern hybridizations 
Northern hybridizations were performed according to the 
procedures of Sambrook et al. (6). 
1. Columns to separate mRNA (purchased from Clontech 
Laboratories, Inc., Palo Alto, CA), were used to extract 
mRNA from total RNA, but hybridizations with the mRNA were 
not very successful, probably because of the low quantities 
of mRNA used (3/ig) . 
2. Total RNA was extracted as described previously, and then 
resolved on a 1% agarose gel for quality inspection. 
3. The samples were prepared by adding 1.1 ill of 10 X MOPS 
buffer, 1.98 /il of 100% formaldehyde, 5.4 /il of 100% 
formamide and 4.3 /il of loading buffer to 50 /ig of rat 
samples and 100 /ig of cow samples respectively. 
4. A denaturing formaldehyde gel was prepared by mixing 1.44 g 
of agarose (Seakem GTG Agarose from FMC Bioproducts) and 
86.6 ml of water. The mixture was microwaved for three 
minutes, and sterile DEPC water was added to it. The 
solution was microwaved for an additional two minutes and 
then cooled. 
5. After adding 12 ml of 10 X MOPS and 21.4 ml of 100% 
formaldehyde to the cool solution,a gel was poured and 
allowed to set for about an hour. 
6. Samples were heated at 65'C for 15 minutes and placed on ice 
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immediately before application to the wells. 
7. The gel was run in 1 X MOPS for two hours at 150 volts, in 
duplicate. One of the duplicate gels was stained for 
resolution and the other duplicate was used for Northern 
hybridization. 
8. The gel to be stained was placed in sterile DEPC water 
(about 500 ml) and left undisturbed overnight. The next 
morning, the gel was placed in 500 ml of sterile DEPC water 
with 150 /il of 1 mg/ml ethidium bromide for one hour. Then 
it was placed in fresh sterile water for another hour to 
destain, after which it could be photographed. 
9. Meanwhile, the gel for Northern hybridization was placed in 
200 ml of 10 X SSC and shaken for 45 minutes at room 
temperature. 
10. A tray was filled with 20 X SSC. A wick of Whatman 3M 
filter paper was cut out, as are three other small pieces. 
11. The Zeta probe membrane was cut to size, and soaked in 
sterile DEPC water for about five minutes. 
12. A glass plate was placed above the tray, and the wick, 
soaked previously in 20 X SSC, was placed on it. Care must 
be taken at each of the following steps to remove air 
bubbles, because these will interfere with efficient 
transfer. 
13. A filter paper and then the gel were placed carefully on 
the wick, taking care that there was sufficient buffer to 
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keep them wet. 
14. A piece of Saran Wrap was placed over the gel, and a window 
was cut out. The membrane was carefully placed on the 
gel, and two more pre-wetted pieces of filter paper were 
placed on it. 
15. The whole apparatus was covered by a glass plate, on 
top of which were placed several paper towels (half a stack) 
and the transfer was allowed to take place overnight. 
16. The next morning, the membrane was carefully removed, after 
drawing the outline of the gel on it, and then baked in a 
vacuum oven at 80°C for exactly two hours. 
17. The blot was then prehybridized, hybridized and resolved 
by autoradiography. Preparation and label separation of the 
radioactive probe were as described previously. 
18. The autoradiograms were read on a light box (Glow Box Model 
GB 11-17, obtained from Instruments for Research and 
Industry, Cheltenham, PA) for clarity. 
Prehvbridization and hvbridization 
1. Half of the prehybridization solution (approximately 50 ml) 
was added to a plastic Seal-a-meal bag with Zeta-Probe 
membrane already in it, sealed shut, and shaken in a 37'C 
waterbath for five minutes. 
2. One corner of the bag was cut, the prehybridization solution 
was poured out, and replaced with the remaining solution 
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(about 50 ml). 
3. Probe preparation was as described for Northern 
hybridization. The denatured probe was added and all bubbles 
were removed before resealing the bag, which was then 
hybridized at 37°C for five minutes. 
4. The hybridization solution was carefully removed by cutting 
one corner, and the hybridized Zeta-Probe membrane was 
extracted. The membrane should not be permitted to dry at 
any stage before washing. 
5. The Zeta-probe membrane was washed twice at 42°C for 
3 0 minutes each with both wash solution I and wash solution 
II. 
6. The membrane was dried in a vacuum oven for 10 minutes, and 
the side of the membrane that was next to the gel was exposed 
to X-ray film, and placed in a cassette with intensifiers at 
-80'C for at least 24 hours. 
IV. Southern hvbridizations 
Southern hybridizations were carried out according to the 
procedures of Sambrook et al. (6) . 
1. Genomic DNA was cut with five different enzymes: EcoRl, 
BamHl, Pst 1, Xho 1, and Hindlll, by adding to 20 nl of DNA 
in a tube, the following: 2 /il of enzyme, 3 /il of 
appropriate buffer, 1 /il of Rnase and 4 /il of water. 
2. The tube was incubated at 37'C for one hour, and the 
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reaction was stopped by adding 20 nl of loading buffer I. 
3. Twenty fig DNA were applied to each lane. Duplicate 1% 
agarose gels in TAE were prepared. 
4. Standards and samples (5 jul sample + 2 /il loading buffer I) 
were heated at 65'C for 15 minutes and then applied on the 
gel for 1.5 hours at 100 volts. 
5. To resolve the DNA, one gel was stained in ethidium 
bromide for 20 minutes, and then destained for about two 
hours. 
6. The DNA was depurinated by soaking the other gel in 0.25 M 
HCl (4 ml concentrated HCl in 200 ml of water) for 10 to 15 
minutes; and then denatured by placing the gel in a bath of 
0.5 N NaOH, 1 M NaCl (100 ml 1 M NaOH, 40 ml 5 M NaCl and 
60 ml water). 
7. The container was placed on a shaker at room temperature for 
30 minutes. 
8. The gel was neutralized by soaking for 30 minutes at room 
temperature on a shaker with a solution of 0.5 M Tris-HCl 
(pH 7.4) and 3 M NaCl (80 ml 1 M Tris, pH 7.4, 120 ml 
5 M Nad) . 
9. The gel was then set up for blotting. Five sheets of 
Whatman 3 MM paper and one sheet of Zeta Probe membrane were 
cut to the exact size of the gel. 
10. The Zeta Probe blotting membrane (Bio-Rad Laboratories, 
Richmond, CA) was soaked in distilled water for five 
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minutes, while the five pieces of Whatman 3 MM paper were 
soaked in 1 X SSC. 
11. A sponge larger than the gel was placed in the bottom of a 
deep dish or tub (two smaller sponges can be aligned 
together snugly without sacrificing transfer efficiency). 
Some commercial sponges have been presoaked in detergent, 
and these should be washed well before using. 
12. Enough 10 X SSC buffer was placed in the transfer dish to 
immerse the sponge about half way up its side. Three sheets 
of the pre-cut Whatman paper were placed on the sponge, and 
the paper surface was flooded with buffer and the gel placed 
on it. Any bubbles were removed from beneath the gel by 
simply pressing them away to the sides. 
13. Saran Wrap plastic wrap, or equivalent plastic wrap, was 
spread over the gel stack. A window was cut with a new 
razor blade, allowing only the gel to emerge from the 
window. This procedure would insure capillary action only 
through the gel. 
14. The surface of the gel was flooded with buffer and the pre 
-wetted Zeta-Probe membrane placed on it. Bubbles were 
carefully removed from underneath the blotting membrane, 
because they would block transfer. To avoid trapping 
bubbles, the Zeta-Probe membrane was placed onto the gel 
surface by first bowing the membrane diagonally and aligning 
the opposite corners with the gel corners. 
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. Then the Zeta-Probe membrane was lowered onto the gel. Any 
bubbles from beneath the membrane were removed by simply 
pressing them away to the side. The blotting membrane 
surface was flooded with buffer. 
. The two remaining pre-cut sheets of Whatman paper were 
wetted, placed on top of the blotting membrane and aligned 
carefully so that they completely covered the blotting 
membrane and did not touch the gel directly. 
17. Any bubbles from beneath each layer of filter paper were 
removed, and dry paper towels were carefully placed over the 
Whatman paper, and stacked about 15 cm high. The paper 
towel stack was covered with a glass or plastic plate, while 
keeping the pressure on the paper towel stack at a minimum 
because excessive weight would compress the gel, retarding 
capillary transfer. 
18. An excess of buffer was kept in the dish, but the top of the 
sponge was not covered. Transfer was continued for 2 to 24 
hours, depending on the gel concentration and fragment size. 
19. After transfer, the membrane was separated from the gel, 
rinsed briefly in 2 X SSC, and air dried. The dried 
membrane was stable at room temperature. 
20. If hybridization was not to be undertaken within two days, 
then the blotted Zeta Probe membrane was vacuum dried at 
80'C for 30 minutes. The membranes can be stored dry 
between two pieces of filter paper in plastic bags at 23 
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to 25*C. Prehybridization, hybridization, washing, and 
exposure to X-ray film were as described for Northern 
hybridizations. 
V. Extraction of mRNA usina columns ffor Northerns) 
This procedure was carried out using mRNA separator columns 
purchased from Clontech Laboratories, Inc., Palo Alto, CA. 
1. Total RNA stored at -80'C was used, to which was added 1/10 
volume 3 M sodium acetate (pH 5.4) and 2.5 to 3.0 volumes of 
ethanol. 
2. The RNA was precipitated at -BO'C for 30 minutes. About 1 
to 4 mg total RNA should be used for optimal recovery. 
3. A recovery of 2 to 6% or 20 to 60 ng mRNA is expected for 
every mg of total RNA run through one cycle of purification. 
4. The precipitated RNA was spun down at 4'C for 15 minutes. 
The supernatant was discarded and the RNA pellet was 
partially dried under vacuum. 
5. The RNA pellet was resuspended in 1.0 ml of elution buffer, 
and heated at 68°C for three minutes. It is important to 
make sure that the RNA is completely dissolved by pipetting 
repeatedly. 
6. The sample was placed on ice and 0.2 ml of sample buffer was 
added to it. The elution buffer was prewarmed to 65'c. The 
sample was loaded on the freshly prepared column and allowed 
to soak in under gravity. 
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7. The oligo (dT)-cellulose was resuspended by inverting the 
spun column several times. The column was placed upright in 
a 50 ml centrifuge tube after removing both the top and 
bottom closures, and the storage buffer was allowed to drain 
through the column. 
8. High salt buffer (1 ml) was added and allowed to drain 
through the column under gravity. This wash was repeated 
once. 
9. The column was removed from the centrifuge tube and the 
buffer that had collected at the bottom of the centrifuge 
tube was discarded. The column was placed back into the 
tube for further use. 
10. The column was centrifuged at 350 x g for two minutes (2000 
rpm in a Beckman TJ-6 centrifuge). The eluate was left at 
the bottom of the 50 ml tube. For a force of 350 x g, 
the centrifuge speed was calculated as follows: 
RCF = 350 = (1.12) (7) (rpm/1000)^ 
where RCF = relative centrifugal force, 
7 = radius in mm measured from the center of the spindle 
to the bottom of the rotor bucket, and 
rpm = revolutions per minute. 
11. High salt buffer (0.25 ml) was applied to this column, which 
was centrifuged at 350 X g for two minutes. This wash was 
repeated once. The eluate collected at the bottom of the 
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50 ml centrifuge tube was discarded. 
12. The column was washed three times with 0.25 ml aliquots of 
low salt buffer, centrifuging at 350 x g each time. The 
column was lifted out of the centrifuge tube, and the buffer 
was collected and discarded. A sterile 1.5 ml 
microcentrifuge tube was placed inside the 50 ml tube to 
collect subsequent eluates. 
13. The column was replaced with its lower end inside the 
microcentrifuge tube. Elution buffer (0.25 ml, warmed to 
65°C) was applied to the column, which was spun at 350 x g 
for two minutes, allowing the poly (A)+ RNA eluate to 
collect in the microcentrifuge tube. This elution was 
repeated three times, for a total of four washes with 
elution buffer to elute bound poly (A)+ RNA. All of the 
eluate was collected in one microcentrifuge tube. 
14. The spun column was removed from the centrifuge tube by 
using sterile forceps. The microcentrifuge tube was placed 
on ice. 
15. The poly (A)+ RNA can be subjected to another round of 
purification by preparing a fresh column as described 
earlier; heating the poly (A)+ RNA eluate at 68°C for 
three minutes, placing on ice, adding 0.2 ml of sample 
buffer, and then repeating the purification procedure by 
loading sample on the freshly prepared column. 
16. Poly (A)+ RNA can be quantitated by UV spectroscopy by using 
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about 1 ml of mRNA. About 50 /lil was removed and brought up 
to 0.8 ml in a 1.0 ml cuvette with double distilled H^O. The 
absorbance at 260 and 280 nm (A^ggand Ajgo) were measured, 
using double distilled HgO as a blank. 
. The formulas used for calculation of yield and purity were: 
Total Ajfio (or ODjso) = (Ajgo) (dilution factor) 
Concentration (jug/ml) = (total A^gg) (40)/(eluate volume) 
Yield (fig) = (volume) (concentration) 
An Ajgo/Ajgo ratio of 1.8-2.0 indicates good purity. 
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APPENDIX E: PREPARATION OF PLASMID DNA FROM CELLS 
The procedures described in this appendix were performed 
according to the procedures of Sambrook et al. (6). 
1. Plating of stock cells 
A colony of frozen stock E. coli Tgfa-1 cells containing 
the pPCKlO plasmid in pBR322 (stored at -BO'C) was inoculated 
into a small flask of LB broth with tetracycline, shaken 
vigorously at 37*C overnight, and grown on agar plates with LB 
broth containing tetracycline. The plates were incubated 
overnight at 37°C and stored at 4*C for about a month. Replating 
was continued every month to keep cells fresh. 
II. Amplification of plasmid DNA 
1. A single bacterial colony of plasmid pPCKlO in the vector 
pBR322 in E.coli Tgf a-1 cells (kindly supplied by Dr. R. W. 
Hanson of Case Western Reserve University, Cleveland, Ohio) 
was used to inoculate 10 ml of LB medium that contained 
10 iJLl of tetracycline. 
2. The inoculated medium was incubated at 37'C overnight with 
vigorous shaking. 
3. The following morning, 25 ml of LB medium in a 100 ml flask 
containing 25 /il tetracycline was inoculated with 0.1 ml of 
the overnight culture. 
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4. This flask was incubated at 37'C with vigorous shaking until 
the cultures reached log phase (O.D. at 600 niti = 0.6, in 
approximately three hours). 
5. Six 250 ml flasks were autoclaved, and 300 ml of prewarmed LB 
medium (with 1 /il tetracycline/ml medium) were distributed 
among them. 
6. The flasks were inoculated with 25 ml of the late log 
culture (4.16 ml/flask), and incubated at 37'C for exactly 
2% hours with vigorous shaking (O.D. at 600 nm = 0.4). 
7. A solution of chloramphenicol (34 mg/ml in ethanol) was 
added to the flasks (0.42 ml/flask) such that the final 
concentration of chloramphenicol in the culture was 
170 /ig/ml. The flasks were incubated at 37'C with vigorous 
shaking for a further 12-16 hours (usually overnight). 
Ill. DNA extraction from cells 
1. The cells containing plasmid DNA were spun down at 
9,000 X g for 10 minutes in a Sorvall Superspeed RC2-B 
automatic refrigerated centrifuge (Ivan Sorvall Inc., 
Norwalk, CT). If DNA was not to be extracted immediately, 
the cells were stored at -80"c for an indefinite period of 
time. 
2. The harvested cells were resuspended in 5 ml solution A 
after adding lysozyme, transferred to a 50 ml capped tube, 
and swirled for one minute out of every five minutes for a 
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total of 20 minutes (four repetitions). 
3. To the tube, 10 ml of solution B was added and shaken for 
five minutes; and then 7.5 ml of ice cold solution C was 
added and the tube was swirled for five minutes. 
4. The tubes were kept on ice for 20 minutes, while swirling 
one out of every five minutes, and then they were 
centrifuged at 9,000 x g for 30 minutes. 
5. The supernatant (take about 20 ml by pipetting to avoid 
flocculant) was transferred to fresh tubes, and 0.6 volumes 
of isopropanol (12 ml) were added. 
6. The tubes were allowed to stand at room temperature for 15 
minutes and then centrifuged at 9,000 x g for one hour. 
7. The pellet was taken up in 5.0 ml of water, 5.0 ml LiCl was 
added and the tube was iced for one hour. 
8. The tubes were spun at 9,000 x g for 15 minutes. 
9. An equal volume (10 ml) of isopropanol was added to the 
supernatant, and tubes were kept at -80°C for one hour, 
after which they were spun at 9,000 x g for 15 minutes. 
10. The pellet was resuspended in 4 ml of TE buffer. About 
1/10 volume 3 M sodium acetate (200 jul) and 2.5 volumes of 
95% ethanol were added to the tubes, which were spun again 
at 9,000 X g for 10 minutes. 
11. The cell pellets were washed with cold 80% ethanol, 
lyophilized in a vacuum oven, and resuspended in 1.0 ml of 
water. 
191 
12. The DNA was resolved on a 1% agarose gel. 
IV. Digestion of DNA 
Digestion of pPCKlO cDNA was performed by adding the 
following reagents to 200 fj.1 of DNA: 30 jul of Pst I 10 X 
buffer, 20 jul of Pst I, 2 fil of RNase, and 48 jul of water (total 
volume 300 Ml)• The contents of the tube were spun down in a 
microfuge to ensure proper mixing, heated at 37°C for one hour, 
and then added to 30 /il loading buffer I (1/10 volume) . The DNA 
was resolved using a 1% agarose gel in IX TAB. 
V. Electroelution of DNA 
1. The cDNA thus extracted and digested must now be purified. 
A 1% agarose gel with a preparative comb was prepared, and 
the molecular weight standards were run in one lane. 
2. Sample (200 jul) was applied to the main well, and the gel was 
run at 120 volts for approximately two hours. After 
resolving the gel by using a UV light box, the bands needed 
were carefully cut out by using a sharp scalpel, placed in a 
dialysis tubing that had been presoaked in 0.1 X TAB, and 
secured. 
3. The bags were placed in an electrophoresis apparatus and 
800 volts were passed through them three times for three 
minutes each, or until all the DNA had been eluted from the 
gel to the tubing (check with UV light). 
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The eluted solution was placed in microfuge tubes, 1/20 
volume of 5 M sodium chloride and 2.5 volumes of 95% ethanol 
were added, and the tubes were spun for 10 minutes in a 
microfuge at 4'C. 
The supernatant was discarded, the tubes were vacuum dried in 
the Speedvac for 20 minutes, and the pellet resuspended in 
50 jul water. 
The electroeluted DNA was resolved on a 1% agarose gel as 
described already. 
This purified cDNA was then used for Northern/Southern 
hybridizations. 
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APPENDIX F: USE OF ACTIN PROBE AS AN INTERNAL STANDARD 
FOR NORTHERN OR SOUTHERN HYBRIDIZATIONS 
The procedures described in this appendix were performed 
according to the procedures of Sambrook et al. (6). 
I. Large scale preparation of plasmid DNA (cleared Ivsate 
method) 
The actin probe (3) used for the analyses was kindly 
supplied by Ms. Julie Johnson and Dr. T. A. Reinhardt at the 
National Animal Disease Center, Ames, lA. 
1. Cells transfected with desired plasmid in 5 ml of LB broth, 
were grown up at 37°C on shaker overnight. (This is the seed 
culture). 
2. The seed culture was added to 1 liter of LB broth containing 
100 mg of ampicillin and was split into two 1-liter flasks 
(500 ml each). The flasks were plugged with sterile gauze 
to allow aeration, and incubated at 37*0 on shaker 
overnight. 
3. The cells were placed in four 250 ml centrifuge bottles with 
caps and spun 10 minutes at 9,000 x g and 4'C. The 
supernatant was discarded. 
4. Each pellet was resuspended in 4 ml of TE + 25% sucrose, and 
stirred with a pipet. All pellets were pooled (about 16 ml 
total) in a 30 ml polycarbonate centrifuge tube with cap, to 
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which 1 ml 1% lysozyme was added by using a sterile pipet 
tip. 
5. After mixing gently and holding for five minutes at room 
temperature, 2 ml of 0.5 M EDTA (pH 8.0) was added, mixed 
gently and left for another five minutes at room 
temperature. 
6. Then 13 ml of Triton Lytic Mix was added slowly, mixing well 
with a pipet to prevent formation of two phases. The tube 
was left for 20 minutes at room temperature, and centrifuged 
again at 48,000 x g (about 20,000 rpm in the Fisher Model 
59A microcentrifuge) for 20 minutes at room temperature. 
7. The supernatant was poured off into a 50 ml graduated 
cylinder, taking care to avoid the fibrous pellet (a few ml 
of supernatant will remain in tube). The supernatant then 
was brought up in volume to 30 ml with TES. 
8. After pouring the supernatant into a 600 ml beaker, slowly 
added 26 g CsCl, mixed to dissolve, and adjusted with CsCl 
or TES until density was 1.59 g/ml. (To measure density: 
The beaker was placed with lysate on scale and zeroed, and 
1 ml was removed with a pipet having a sterile tip. The 
reading should be -1.59 g). 
9. The lysate was placed into 5 ml Beckman Quick Seal tubes 
with a sterile 16 g needle and syringe or Pasteur pipet, 
taking care to avoid shearing DNA, and filling tubes to the 
neck. The lysate may be stored at 4'C overnight if needed. 
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10. Just before getting ready to centrifuge, 100 jitl of 10 mg/ml 
ethidium bromide was added by using a special gel loading 
tip, trying to put ethidium bromide in the center of the 
tube. The tubes were filled with CsCl/TES with a density of 
1.59 g/ml if not full already, and sealed (EtBr may cause 
nicking of plasmid under light). 
11. The tubes were placed in a SW 41 Ti rotor in a Beckman L8-70 
ultracentrifuge (Beckman Instruments Inc., Palo Alto, CA), 
and the outer cap was screwed on to a torque of 90 to 100 
units on the torque gauge. 
12. The tubes were ultracentrifuged at 15'C, 45,000 x g 
overnight or at 58,500 x g for four hours. The centrifuge 
was allowed to brake to about 9,000 x g, when the brake was 
turned off (deceleration = 0), and the tubes were removed 
when the rotor stopped turning. The upper thin band is 
linear DNA, and the lower band is supercoiled plasmid. 
13. In a darkroom with UV light, the top of the tube was pierced 
with a 16 g needle to let air in, and another 16 g needle 
was placed on a 5 ml syringe and inserted just below the 
plasmid band (this should be done quickly to prevent DNA 
leaking out). 
14. The plasmid band was pulled into the syringe, and then 
transferred to a 15 ml conical tube, by removing the syringe 
plunger and letting the DNA solution flow out by gravity to 
prevent shearing. 
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15. This process was repeated for all tubes, and all the plasmid 
was pooled into one conical tube. 
16. Ethidium bromide was extracted from the solution with 
1 volume of isopropanol saturated with 5 M NaCl. The top 
layer was discarded. Complete removal will take 3 to 5 
extractions. 
17. On the last extraction, most of the top layer was removed, 
then the lower plasmid layer was transferred to a new tube. 
The plasmid may now be stored indefinitely in CsCl at 4°C. 
18. To precipitate the plasmid, the following were added per 
1 ml plasmid in CsCl: 3 ml of sterile water, 0.4 ml of 3 M 
NaOAc, and 10 ml of cold 100% EtOH. The contents were 
mixed and precipitated at -20'c overnight; and then 
centrifuged at about 4,000 x g (approximately 6500 rpm) for 
25 minutes to precipitate the plasmid. 
19. The supernatant was poured off carefully and the pellet was 
allowed to dry for a few minutes upside down on a paper 
towel. The pooled pellets were resuspended in a total 
volume of 400 /il TE, and transferred to a microfuge tube. 
20. The plasmid was reprecipitated with 40 jul of 3 M sodium 
acetate (or 60 /nl of 2 M sodium acetate) and 1 ml of 100% 
ethanol, placed at -20*C for a short time, and spun at high 
speed in a microfuge for five minutes. 
21. The pellet was washed with cold 75% ethanol and dried 
carefully under nitrogen or under vacuum. 
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22. The pellet was resuspended in 500 (il of TE (65'C water bath 
may be needed) and stored at 4*C (nicking will occur at 
-20'C). 
23. A 1:100 dilution was made (with TE) to quantitate plasmid 
DNA. A quartz cuvette was used and zeroed with TE, and the 
sample was read. The ratio of A^go/A^gQ will be greater than 
or equal to 1.8 for a pure sample. To calculate 
concentration of plasmid, the following formula was used: 
mg dsDNA/ml TE = (A260) (0.05 mg DNA/ml dil.) (100 ml 
dil./ml TE) 
Cutting out 6-actin cDNA insert from the plasmid 
1. The following solutions were mixed in a tube to perform a 
test cut: 1 fj,g of plasmid DNA, 20 /il of sterile water, 2 fj.1 
of 10 X Hind III buffer, 1 u of Hind III (total volume 
20 /il) . 
2. The reaction was stopped after one hour with 2.2 ill of 10 X 
DNA loading dye. About 2 /tl of 10 mg/ml EtBr was added to 
the tube, which was incubated for one hour at 37°C. 
3. The DNA was resolved on a mini gel (1% agarose in IX TAE) at 
100 volts for about 30 minutes (1 /tg of uncut plasmid was 
also run alongside as a control). 
4. About 100 /ig of plasmid was used for preparative digests -
other components were adjusted accordingly (use 1 u enzyme, 
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1 ng DNA). 
5. About 10® cpm of probe/ml of hybridization fluid (5 ml per 
11 X 14 cm membrane) was used for Northern, Southern, and 
slot-blot hybridizations. 
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APPENDIX G: PROTEIN ANALYSES 
I. Protein extraction 
1. Proteins were extracted from liver tissue by the method of 
Sambrook et al. (6). Approximately one gram of tissue was 
homogenized in a Polytron homogenizer with 10 ml of buffer 
(0.25 M sucrose and 20 mM HEPES, pH 7.5) for 10 seconds, 
filtered through one layer of cheesecloth and centrifuged at 
9,000 X g at 4°C for 15 minutes. The supernatant contains 
the cytosol and the pellet the mitochondria. 
2. The O. D. of proteins was read by using the Bradford assay 
(2) at 595 nm. Coomassie Brilliant Blue G-250 was obtained 
from Sigma, as was 2-mercaptoethanol, SDS and Triton X-100. 
3. The protein reagent was prepared as follows: Coomassie 
Brilliant Blue G-250 (100 mg) was dissolved in 50 ml 
of 95% ethanol. To this solution added 100 ml 85% (w/v) 
phosphoric acid. The resulting solution was diluted to a 
final volume of 1 liter. Final concentrations in the 
reagent mixtute were 0.01% (w/v) Coomassie Brilliant Blue G 
-250, 4.7% (w/v) ethanol, and 8.5% (w/v) phosphoric acid. 
4. Protein solutions containing 10 to 100 ng of protein in a 
volume up to 0.1 ml were pipetted into 12 X 100 test tubes. 
5. The volume in the test tube was adjusted to 0.1 ml with 
appropriate buffer, and 5 ml of protein reagent was added 
to the test tube. The contents were mixed by inversion. 
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6. The absorbance at 595 nm was measured after two minutes and 
before one hour in 3 ml cuvettes against a reagent blank 
prepared from 0.1 ml of the appropriate buffer and 5 ml of 
protein reagent. The weight of protein was plotted against 
the corresponding absorbance resulting in a standard curve 
used to determine the protein in unknown samples. 
7. BRL (Bethesda Research Laboratories) high molecular weight 
protein standards were used as controls. SDS-PAGE gels 
(12.5%) were prepared, and about 50 jug of protein were 
loaded per well with 4X Laemmli loading buffer (ratio of 
3:1). 
8. The gels were run at 200 volts for one hour. The apparatus 
used were Mighty Small II SE 250 electrophoresis minigel 
apparatus and Model TE 22 mini Transfer apparatus (both 
from Hoefer Scientific Instruments, San Francisco, CA). 
9. The protocol used for analysis of proteins was based on 
information from Ausubel et al. (1). The gels were always 
run in duplicate. One half was stained in Coomassie Blue 
solution for 30 minutes, and then destained in 
methanol:acetic acid:water (100:179:21) overnight or until 
clear bands are seen. The other half was used for transfer 
to nitrocellulose. 
10. Western transfer of proteins to nitrocellulose was performed 
in the transfer apparatus at 350 mamps for one hour. 
11. The nitrocellullose was treated with blocking solution (IX 
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RB + 2% BSA) at 4*C overnight (5 ml/gel). 
12. Primary antibody, goat anti-PEPCK antibody, (kindly supplied 
by Dr. D. K. Granner of Vanderbilt University, Nashville, 
TN) was added at a dilution of 1:50, and the membrane was 
shaken at room temperature for two hours. 
13. After one quick rinse for five minutes, the membrane was 
washed three times for ten minutes each time with shaking in 
100 to 200 ml of IX RB. 
14. The blot (membrane) was bagged in RB-BSA. The secondary 
antibody, '"l-prot A (specific activity 87.4 nci/nq, 
purchased from NEN Research Products, Du Pont Company, 
Biotechnology Systems, Wilmington,DE) was injected at 
5/il/blot and incubated at room temperature for two hours. 
15. After rinsing three times in RB-Hisalt (250 ml 2X RB, 100 ml 
5M sodium chloride and 150 ml water), at 30 minutes each, 
the blot was air dried under a lamp in the hood, and exposed 
to X-ray film for a week. 
II. Quantitation of autoradiocrrams 
Both the RNA and protein were quantified by using a 
scanning densitometer (Zeineh Soft Laser Scanning Densitometer, 
Model SL-504-XL, obtained from Biomed Instruments Inc. , 
Fullerton, CA, and LKB Bromma 2202 Ultrascan Laser Densitometer, 
and LKB Bromma 2220 Recording Integrator, obtained from LKB-
Produkter AB Electrophoresis Products, Bromma, Sweden). 
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APPENDIX H: RAW DATA FROM ANALYSES 
I. Raw liver PEPCK mRNA data' 
Stage of experiment' 
Cow Treatment*" 
-10 5 14 21 28 35 42 49 63 
9106 NC 15. 3 16. 5 16.8 18. 3 21 .9 23 .9 21 .8 16 . 6 15. 4 
9132 NC 10. 4 11. 2 11.7 15. 6 17 .2 15 . 6 11 .9 16. 3 
9604 NC 17. 9 18. 9 18.5 21. 9 16 .4 21 .6 26 .4 22 .5 16. 0 
9622 NC 24. 1 26 .5 1 23.9 31 .1 29 .6 23 .1 25 .8 15. 7 
9692 NC 17. 9 18. 9 16.3 15. 9 21 .6 28 .7 26 .8 20 .5 16. 5 
9237 NFRBD 23. 8 23 . 1 24.3 - 24 .1 37 .2 15 .0 17. 2 
9294 NFRBD 9. 0 10. 5 8.6 12. 3 14 .8 12 .8 11 .7 10 , 0 
9464 NFRBD 11. 4 11. 8 14.2 16. 5 15 .9 18 .5 15 .4 13 .7 14. 4 
9698 NFRBD 19. 4 20. 6 22.5 16. 9 25 .4 28 .9 14 . 2 14 .9 21. 3 
9718 NFRBD 9. 3 9. 9 13.2 16. 4 13 .0 15 .9 15 .3 9 .8 10. 4 
9334 OC 19. 8 20. 1 19.4 21. 7 19 .9 23 .7 22 .7 18 .8 19. 4 
9509 OC 11. 1 11. 9 17.5 15. 7 16 .6 18 .3 17 .9 17 .5 16. 3 
9606 OC 18. 6 18. 0 18.8 20. 1 25 .3 26 .8 23 .8 20 .4 16. 4 
9557 OFRBD 12. 9 16. 2 14.2 13. 2 16 .2 17 .6 14 .3 13 .6 15. 3 
9605 OFRBD 15. 3 20. 9 20.2 14. 9 20 .0 18 .8 15 .5 18 .4 14. 5 
9286 OFRBD 17. 4 22. 6 19.8 20 .3 22 .6 19 .1 19 .3 20. 1 
9671 OFRBD 12. 9 18. 0 17.4 16. 7 16 .8 18 .3 14 .5 14 .1 
9442 OFRBD 10. 9 6.9 12. 0 13 .2 14 .6 13 .1 13 .5 14. 7 
"All values are in integrator units. 
•"NC refers to normal weight controls, NFRBD to normal weight 
FRBD-treated cows, OC to obese controls, and OFRBD to obese 
FRBD-treated cows. 
'The stages of experiment refer to days peripartum, with day of 
parturition as d 0. Missing data are represented as . 
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II. Raw liver PEPCK protein data' 
Stage of experiment® 
Cow Treatment*" 
-10 5 14 21 28 35 42 49 63 
9106 NC 17. 3 19. 1 18. 9 20. 2 23 . 1 24. 6 23. 5 20. 3 18. 2 
9132 NC 18. 4 19. 8 19. 1 22. 1 25. 0 26. 1 25. 3 22. 2 20. 3 
9604 NC 20. 8 22. 7 22. 9 24. 1 26. 8 27. 9 24. 2 25. 6 23. 1 
9622 NC 15. 5 17. 2 16. 8 18. 5 21. 2 21. 6 20. 4 18. 9 17. 5 
9692 NC 14. 8 16. 9 16. 5 17. 8 19. ,3 23, .1 22. ,5 18, .5 17. 3 
9237 NFRBD 16. 4 16. 8 17. 1 20. 3 22. 7 23. 5 18. 2 16. 7 16. 9 
9294 NFRBD 17. 6 18. 1 19. 6 21. 9 23. 2 24. 1 20. 3 17. 9 18. 2 
9464 NFRBD 15. 9 16. 3 17. 7 21. 4 23. ,8 23 . ,9 18, .4 16, .8 16, .9 
9698 NFRBD 20. 1 20. 6 21. 8 24. 3 25. 9 25. 4 23. 1 20. 9 21. 3 
9718 NFRBD 13 . 5 13. 7 14. 3 16. 9 18. 8 20. 6 14. 7 12. 8 12. 5 
9334 OC 16. 9 16. 7 19. 2 19. 8 20. 2 21. 6 21. 3 18. 4 18. 3 
9509 OC 14. 6 14. 7 18. 5 18. 9 21. 3 22. 9 19. 6 23 . 0 21. 7 
9606 OC 20. 1 20. 6 22. 3 22. 7 24. 6 26. 3 27. 1 23 . 5 23. 4 
9557 OFRBD 20. 6 19. 5 19. 9 19. 6 21. 1 23. 3 19. 2 20. 3 21. 7 
9605 OFRBD 13. 3 12. 8 15. 4 14. 5 15. 8 16. 4 12. 5 12. 9 14. 4 
9286 OFRBD 14. 5 13. 1 13. 7 14. 4 17. 8 18. 5 15. 1 15. 5 16. 3 
9671 OFRBD 18. 4 17. 5 19. 5 17. 6 20. 5 21. 9 18. 3 18. 7 19. 8 
9442 OFRBD 16. 8 15. 6 16. 3 16. 8 19. 4 21. 7 18. 3 18. 1 19. 5 
'All values are in integrator units. 
•"NC refers to normal weight controls, NFRBD to normal weight 
FRBD-treated cows, OC to obese controls, and OFRBD to obese 
FRBD-treated cows. 
'The stages of experiment refer to days peripartum, with day of 
parturition as d 0. Missing data are represented as . 
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III. Raw liver glycogen data* 
Stage of experiment® 
Cow Treatment*" 
-10 5 14 21 28 35 42 49 63 
9132 NC 2.50 1.94 2. 69 - 2.17 — 1.94 3. 65 -
9604 NC - 2.83 3.45 - 3.90 3.18 2.86 3. 22 -
9237 NFRBD 3.29 1.19 1.68 - 0.87 4.29 2.46 3. 19 -
9464 NFRBD 2.61 1.80 1.46 - 2.76 2.36 1.37 1. ,43 -
9334 OC 1.15 1.09 2.03 - 1.58 2.90 2.62 1. 23 -
9606 OC - 2.03 2.62 - 3.76 4.01 3.37 4. 22 -
9557 OFRBD 4.95 1.95 0.15 - - 1.53 3.28 — — 
9286 OFRBD 1.94 3.06 3.09 4.75 3.83 3. 56 -
"All values are in integrator units. 
••NC refers to normal weight controls, NFRBD to normal weight 
FRBD-treated cows, OC to obese controls, and OFRBD to obese 
FRBD-treated cows. 
'The stages of experiment refer to days peripartum, with day of 
parturition as d 0. Missing data are represented as . 
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IV. Raw liver triacylglycerol data" 
Stage of experiment® 
Cow Treatment*" 
-10 5 14 21 28 35 42 49 63 
9132 NC 0.89 2.12 1.96 - 1.15 - 0.75 0.28 
9604 NC - 5.65 2.95 - 2.12 1.03 4.40 2.38 
9237 NFRBD 1.01 6.77 1.24 - 5.89 4.69 3.56 0.34 
9464 NFRBD 0.32 2.55 1.05 - 0.85 1.74 0.43 0.87 
9334 OC 0.66 15.13 14.80 - 11.33 7.56 3.24 3.58 
9606 OC - 20.61 11.07 - 11.33 11.33 1.27 0.81 
9557 OFRBD 1.06 5.62 7.99 - - 5.31 2.04 — — 
9286 OFRBD — 6.39 2.84 - 2.79 1.83 1.22 0.63 
'All values are in integrator units. 
•"NC refers to normal weight controls, NFRBD to normal weight 
FRBD-treated cows, OC to obese controls, and OFRBD to obese 
FRBD-treated cows. 
'The stages of experiment refer to days peripartum, with day of 
parturition as d 0. Missing data are represented as 
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